Helix-loop-helix transcription factors

Protein Profile

Volumn , Issue 3rd, 1998, Pages 1-138

  Littlewood, Trevor D ^a   Evan, Gerard I ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 7244250768     PISSN: 10703667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (889)

1. Adams, J. M. and S. Gory. 1991. Transgenic models for haemopoietic malignancies. Biochim. Biophys. Acta. 1072: 9-31.
2. Bernards, R. 1995. Transcriptional regulation. Flipping the Myc switch. Curr. Biol. 5: 859-861.
3. Berns, A., N. van der Lugt, M. Alkema, M. van Lohuizen, J. Domen, D. Acton, J. Alien, P. W. Laird, and J. Jonkers. 1994. Mouse model systems to study multistep tumorigenesis. Cold. Spring. Harb. Sjmp. Quant. Biol. 59: 435-447.
4. Buckingham, M. 1994. Muscle differentiation. Which myogenic factors make muscle? Curr. Biol. 4: 61-63.
5. Cross, F. 1995. Transcriptional regulation by a cyclin-cdk. Trends. Genet. 11: 209-211.
6. Dias, P., M. Dilling, and P. Houghton. 1994. The molecular basis of skeletal muscle differentiation. Semin. Diagn. Pathol. 11: 3-14.
7. Eisenman, R. N. and J. A. Cooper. 1995. Signal transduction. Beating a path to Myc. Nature 378: 438-439.
8. Evan, G., E. Harrington, A. Fanidi, H. Land, B. Amati, and M. Bennett. 1994. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos. Trans. R. Soc. Lond. B. biol. Sei. 345: 269-275.
9. Hankinson, O. 1993. Research on the aryl hydrocarbon (dioxin) receptor is primed to take off. Arch. Biochem. Biophjs. 300: 1-5.
10. Hankinson, O. 1995. The arvl hydrocarbon receptor complex. Ann. Rev. Pharmacol. Toxicol. 35: 307-340.
11. Hoffman, B., D. A. Liebermann, M. Selvakumaran, and H. Q. Nguyen. 1996. Role of c-myc in myeloid differentiation, growth arrest and apoptosis. Curr. 'lop. Microbiol. linmnnol. 211: 17-27.
12. Hurlin, P. J., D. E. Ayer, C. Grandori, and R. N. Eisenman. 1994. The Max transcription factor network: involvenent of Mad in differentiation and an approach to identification of target genes. Cold. Spring. Harb. Sjmp.Quam. biol. 59: 109-116.
13. Kageyama, R., Y. Sasai, C. Akazawa, M. Ishibashi, K. Takebayashi, C. Shimizu, K. Tomita, and S. Nakanishi. 1995. Regulation of mammalian neural development by helix-loop-helix transcription factors. Crit. Ra: Keurobi.il. 9: 177-188.
14. Krause, M. 1995. MyoD and myogenesis in C. elegant. Bioessays 17: 219-228.
15. Moore, K. J. 199.5. Insight into the microphthalmia gene. Trends. Genet. 11: 442-448.
16. Morgenbesser, S. D. and R. A. DePinho. 1994. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Strain. Cancer. Rial. 5: 21 -36.
17. Muller, R., D. Mumberg, and F. C. Lucibello. 1993. Signals and genes in the control of cell-cycle progression. Biacl.im. Biophys. Ac/a. 1155: 151 -179.
18. Murre, C., G. Bain, M. A. van Dijk, I. Engel, B. A. Furnari, M. E. Massari, J. R. Matthews, M. W. Quong, R. R. Rivera, and M. H. Stuivet. 1994. Structure and function of helix-loop -heli> proteins. Biochim. Biophys. Acfa 1218: 129-135.
19. Muscat, G. E., M. Downes, and D. H. Dowhan. 1995. Regulation of vertebrate muscle differentiation bythyroid hormone rhe role of the myoD gene family. Bioessays 17: 211-218.
20. Rudnicki, M. A. and R. Jaenisch. 1995. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17: 203-209.
21. Skeath, J. B. and S. B. Carroll. 1994. The achaete-scute complex: generation of cellular pattern and fate within the Drosophita nervous system. FASEB. J. 8: 714-721.
22. Vastrik, I., T. P. Makela, P. J. Koskinen, . Klefstrom, and K. Alitalo. 1994. Myc protein: partners and antagonists. Crit. Rev. Oncog. 5: 59-68.
23. Wenzel, A. and M. Schwab. 1995. The mycN/max protein complex in neuroblastoma. Short review. Eur. J. Cancer 31A: 516-519.
24. Sequences, expression and functions of HLH proteins
25. Abbott, B. D., L. S. Birnbaum, and G. H. Perdew. 1995. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev. Dyn. 204: 133-143.
26. Abbott, B. D., M. R. Probst, and G. H. Petdew. 1994. Immunohistochemical double-staining for Ah receptor and ARNT in human embryonic palatal shelves. Teratology SO: 361 -366.
27. Adams, J. M., H. Houston, J. Allen, T. Lints, and R. Harvey. 1992. The hematopoietically expressed vav proto-oncogene shares homology with the dbl CrDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene. 1: 611-618.
28. Adams, L., B. M. Carlson, L. Henderson, and D. Goldman. 1995. Adaptation of nicotinic acetylcholine receptor, myogenin, and MRF4 gene expression to long-term muscle denervation. J. Cell biol. 131: 1341-1349.
29. Adnane, J. and P. D. Robbins. 1995. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. Qncogem. 10: 381-387.
30. Agrawal, R. S., Y. P. Agrawal, and R. A. Mantyjarvi. 1994. Flow cytometnc quantitation of C-myc and P53 proteins in bovine papillomavirus type 1-transformed primary mouse fibroblasts. Cytometry. 17: 237-245.
31. Akazawa, C., M. Ishibashi, C. Shimizu, S. Nakanishi, and R. Kageyama. 1995. A mammalian helix -loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. J. biol. Chem. 270: 8730-8738.
32. Albanese, I., M. Alberti, V. Bazan, A. Russo, S. Baiamonte, M. Migliavacca, P. Bazan, and M. La Farina. 1994. Structural analysis of c-myc in human sporadic colorectal carcinomas. Anticancer. Res. 14: 1103-1106.
33. Albert, D. A. 1995. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells. J. Clin. Invest. 95: 1490-1496.
34. Alexandrow, M. G., M. Kawabata, M. Aakre, and H. L. Moses. 1995. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor \. P roc. N all. Acad. Sei. U. S. A. 92: 3239-3243.
35. Allende, M. L. and E. S. Weinberg. 1994. The expression pattern of two zebrafish achaete-scute homolog (ash) genes is altered in the embryonic brain of the cyclops mutant. Dei'. biol. 166: 509-530.
36. Alleva, D. G., D. Askew, C. J. Burger, and K. D. Elgert. 1994. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms. Immunol. Invest. 23: 457-472.
37. Ambinder, R. F., M. A. Müllen, Y. N. Chang, G. S. Hay ward, and S. D. Hay ward. 1991. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65: 1466-1478.
38. Ambroziak, J. and S. A. Henry. 1994. INO2 and INO4 gene products, positive regulators of phospholipid biosynthesis in Saccharomyces cerevisiae, form a complex that binds to the INO1 promoter. J. biol. Chem. 269: 15344-15349.
39. Amendola, R. 1994. Course of c-myc mRNA expression in the regenerating mouse testis determined by competitive reverse transcriptase polymerase chain reaction. DNA Cell Biol. 13: 1099-1107.
40. Amundadottir, L. T., M. D. Johnson, G. Merlino, G. H. Smith, and R. B. Dickson. 1995. Synergistic interaction of transforming growth factor a and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth. Differ. 6: 737-748.
41. Anderson, D. J. 1993. MASH genes and the logic of neural crest cell lineage diversification. C. R. Acad. Sei. HI. 316: 1082-1096.
42. Andres, V. and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132: 657-666.
43. Antonsson, C., V. Arulampalam, M. L. Whitelaw, S. Pettersson, and L. Poellinger. 1995. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. Regulation of target promoters via the E box motif.J. Biol. Chem. 270: 13968-13972.
44. Antonsson, C., M. L. Whitelaw, J. McGuire, J. A. Gustafsson, and L. Poellinger. 1995. Distinct roles of the molecular chaperone hsp90 in modulating dioxin receptor function via the basic helix-loop-helix and PAS domains. Mol. Cell Biol. 15: 756-765.
45. Araki, I., H. Saiga, K. W. Makabe, and N. Satoh. 1994. Expression of amdl, a gene for a myoDl-related factor in the ascidian Halocynthia roret^i. Roux's Arch. Devel. Biol. 203: 320-327.
46. Arbiser, J. L., Z. K. Arbiser, and J. A. Majzoub. 1993. Effects of hydroxyurea and cyclic adenosine monophosphate/protein kinase A inhibitors on the expression of the human chorionic gonadotropin a subunit and c-myc genes in choriocarcinoma. J. Endocrinol. Invest. 16: 849-856.
47. Arcinas, M. and L. M. Boxer. 1994. Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell lines. Oncogene. 9: 2699-2706.
48. Arcinas, M., K. C. Sizer, and L. M. Boxer. 1994. Activation of c-myc expression by c-Abl is independent of both the DNA binding function of c-Abl and the c-myc EP site. J. biol. Chem. 269: 21919-21924.
49. Arenas, M. J., A. H. McGregor, and A. H. Wyllie. 1994. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am. J. Pathol. 144: 1045-1057.
50. Argenton, F., Y. Arava, A. Aronheim, and M. D. Walker. 1996. An activation domain of the helix-loop-helix transcription factor E2A shows cell type preference in vivo in microinjected Zebra fish embryos. Mol. Cell. biol. 16: 1714-1721.
51. Arnold, T. E., R. A. Worrell, J. L. Barth, J. Morris, and R. Ivarie. 1994. Dexamethasone-mediated induction of MMTV-myf5 in DD3 myoblasts increases endogenous myogenin expression but does not transactivate myf5. Exp. Cell Res. 212: 321-328.
52. Aronheim, A., R. Shiran, A. Rosen, and M. D. Walker. 1993. The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. NatJ. Acad. Sei. U. S. A. 90: 8063-8067.
53. Arsura, M., A. Deshpande, S. R. Hann, and G. E. Sonenshein. 1995. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation. Mol. Cell biol. 15: 6702-6709.
54. Artandi, S. E., C. Cooper, A. Shrivastava, and K. Calame. 1994. The basic helix-loop-helix- zipper domain of TFE3 mediates enhancer- promoter interaction. Mol. Cell biol. 14: 7704-7716.
55. Artandi, S. E., K. Merrell, N. Avitahl, K. K. Wong, and K. Calame. 1995. TFE3 contains two activation domains, one acidic and the other proline-rich, that synergistically activate transcription. Nucleic Acids Res. 23: 3865-3871.
56. Asadi, F. K. and R. Sharifi. 1995. Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines. Int. Ural. Nepbrol. 27: 67-80.
57. Asai, A., Y. Miyagi, H. Hashimoto, S. H. Lee, K. Mishima, A. Sugiyama, H. Tanaka, T. Mochizuki, T. Yasuda, and Y. Kuchino. 1994. Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo. Cell Growth. Differ. 5: 1153-1158.
58. Asai, A., Y. Miyagi, A. Sugiyama, M. Gamanuma, S. H. Hong, S. Takamoto, K. Nomura, M. Matsutani, K. Takakura, and Y. Kuchino. 1994. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J. Neurooncol. 19: 259-268.
59. Asao, H., N. Tanaka, N. Ishii, M. Higuchi, T. Takeshita, M. Nakamura, T. Shirasawa, and K. Sugatnura. 1994. Interleukin 2-induced activation of JAK3:possible involvement in signal transduction for c-myc induction and cell proliferation. FEES Lett. 351: 201-206.
60. Ashburner, B. P. and J. M. Lopes. 1995. Autoregulated expression of the yeast INO2 and INO4 helix-loop-helix activator genes effects cooperative regulation on their target genes. Mol. Cell biol. 15: 1709-1715.
61. Asher, O., S. Fuchs, and M. C. Souroujon. 1994. Acetylcholine receptor and myogenic factor gene expression in Torpedo embryonic development. Neuroreport. 5: 1581-1584.
62. Asket, C. E., K. P. Magnusson, S. P. Piccoli, K. Andersson, G. Klein, M. D. Cole, and K. G. Wiman. 1995. Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. Oncogene. 11: 1963-1969.
63. Atchley, W. R. and W. M. Fitch. 1995. Myc and Max:molecular evolution of a family ot proto-oncogene products and their dimerization partner. Proc. NatJ. Acad. Sei. U. S. A. 92: 10217-10221.
64. Atchley, W. R., W. M. Fitch, and M. Bronner Fräser. 1994. Molecular evolution of the MyoD family of transcription factors. Proc. Natl. Acad. Sei. U. S. A. 91: 11522-11526.
65. Aurade, F., C. Pins, P. Chafey, F. Gros, and D. Montarras. 1994. Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype. Differentiation. 55: 185-192.
66. Axelson, H., M. Henriksson, Y. Wang, K. P. Magnusson, and G. Klein. 1995. The amino terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. Ear. J. Cancer 31A: 2099-2104.
67. Axelson, H., Y. Wang, S. Suva, M. G. Mattei, and G. Klein. 1994. Juxtaposition of N-myc and Ig K through a reciprocal t(6;12) translocation in a mouse plasmacytoma. Genes. Chromosom. Cancer 11: 85-90.
68. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell. 80: 767-776.
69. Azzoni, L., I. Anegon, B. Calabretta, and B. Perussia. 1995. Ligand binding to Fc 7 R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Imrnunol. 154: 491 -499.
70. Bacsi, S. G. and O. Hankinson. 1996. Functional characterization or DNA-binding domains of the subunits of the heterodimeric aryl hydrocarbon receptor complex imputing novel and canonical basic helix-loop-helix protein-DNA interactions. J. biol. Chem. 271: 8843-8850.
71. Bai, M. K., J. S. Costopoulos, B. P. Christoforidou, and C. S. Papadimitriou. 1994. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. Oncology. 51: 314-319.
72. Bailey, A. M. and J. W. Posakony. 1995. Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes. Dev. 9: 2609-2622.
73. Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlisse], A. J. Feeney, M. van Roon et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Ce/179: 885-892.
74. Baker, D. A., J. Mäher, I. A. Roberts, and N. J. Dibb. 1994. Evidence that ras and myc mediate the synergy between SCF or M-CSF and other haemopoietic growth factors. Leukemia: 1970-1981.
75. Baker, S. J., M. Pawlita, A. Leutz, and D. Hoelzer. 1994. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells. Leukemia 8: 1309-1317.
76. Barone, M. V. and S. A. Courtneidge. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378: 509-512.
77. Barrera, G., R. Muraca, S. Pizzimenti, A. Serra, C. Rosso, G. Saglio, M. G. Farace, V. M. Fazio, and M. U. Dianzani. 1994. Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. Biochem. Biophys, Res. Commun. 203: 553-561.
78. Barrett, J. F., B. C. Lewis, A. T. Hoang, R. J. J. Alvarez, and C. V. Dang. 1995. Cyclin A links c-Myc to adhesion-independent cell proliferation. J. biol. Chem. 270: 15923-15925.
79. Barrios, C., J. S. Castresana, U. G. Falkmer, I. Rosendahl, and A. Kreicbergs. 1994. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms. Int. J. Cancer 58: 781-786.
80. Barrios, C., J. S. Castresana, and A. Kreicbergs. 1994. Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification. Am. J. Clin. Oncol. 17: 273-276.
81. Bartholoma, A. and K. A. Nave. 1994. NEX-1: a novel brain-specific helix-loop-helix protein with autoregulation and sustained expression in mature cortical neurons. Mech. Dev. 48: 217-228.
82. Basu, A. and J. S. Cline. 1995. Oncogenic transformation alters cisplatin-induced apoptosis m rat embryo fibroblasts. Int. ]. Cancer 63: 597-603.
83. Baylies, M. K. and M. Bate. 1996. twist-, a myogenic swith in Drosophila. Science 272: 1481-1484.
84. Bazar, L., V. Harris, I. Sunitha, D. Hartmann, and M. Avigan. 1995. A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth. Oncogem. 10: 2229-2238.
85. Bazar, L., D. Meighen, V. Harris, R. Duncan, D. Levens, and M. Avigan. 1995. Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc. J. biol. Chem. 270: 8241-8248.
86. Ben Baruch, N., W. C. Reinhold, N. Alexandrova, I. Ichinose, M. Blake, J. B. Trepel, and M. Zajac Kaye. 1994. c-myc down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation. Mol. Pharmacol. 46: 73-78.
87. Benharroch, D., T. Yermiahu, D. B. Geffen, I. Prinsloo, J. Gopas, S. Segal, and M. Aboud. 1995. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease. Ear. J. Haematol. 55: 178-183.
88. Bennett, M. K., J. M. Lopez, H. B. Sanchez, and T. F. Osborne. 1995. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J. biol. Chem. 270: 25578-25583.
89. Bennett, M. R., D. F. Gibson, S. M. Schwartz, and J. F. Tait. 1995. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ. Res. 77: 1136-1142.
90. Bennett, M. R., T. D. Littlewood, D. C. Hancock, G. I. Evan, and A. C. Newby. 1994. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? Kochern. J. 302: 701-708.
91. Bentley, N. J., T. Eisen, and C. R. Coding. 1994. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell biol. 14: 7996-8006.
92. Berberich, S., A. Trivedi, D. C. Daniel, E. M. Johnson, and M. Leffak. 1995. In vitro replication of plasmids containing human c-myc DNA. J. Mol. Biol. 245: 92-109.
93. Berberich, S. J. and E. H. Postel. 1995. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene. 10: 2343-2347.
94. Berebbi, M., C. Cajean Feroldi, F. Apiou, J. Couturier, M. Garcette, R. Emanoil Ravier, J. Cabannes, M. Perricaudet, and D. Blangy. 1995. Integration of viral sequences into the c-myc gene in two mammary adenocarcinomas induced by polyomavirus in athymic nude mice. J. Viral. 69: 5935-5945.
95. Betghard, A., K. Gradin, I. Pongratz, M. Whitelaw, and L. Poellinger. 1993. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol. Cell biol. 13: 677-689.
96. Bernard, M., L. Smit, E. Macintyre, D. Matthieu Mahul, and K. Pulford. 1995. Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain. Blood. 85: 3356-3357.
97. Bhatia, K., G. Spangler, G. Gaidano, N. Hamdy, R. Dalla Favera, and I. Magrath. 1994. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood. 84: 883-888.
98. Bhatia, K., G. Spangler, N. Hamdy, A. Neri, G. Brubaker, A. Levin, and I. Magrath. 1995. Mutations in the coding region of c-myc occur independently of mutations in the regulatory regions and are predominantly associated with myc/Ig translocation. Curr. Top. Microbiol. Immunol. 194: 389-398.
99. Bieche, I., M. H. Champeme, and R. Lidereau. 1994. A tumor suppressor gene on chromosome Ip32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res. 54: 4274-4276.
100. Black, B. L., J. F. Martin, and E. N. Olson. 1995. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. biol. Chem. 270: 2889-2892.
101. Blackwood, E. M., T. G. Lugo, L. Kretzner, M. W. King, A. J. Street, O. N. Witte, and R. N. Eisenman. 1994. Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. Mol. biol. Cell 5: 597-609.
102. Blanar, M. A., P. H. Crossley, K. G. Peters, E. Steingrimsson, N. G. Copeland, N. A. Jenkins, G. R. Martin, and W. J. Rutter. 1995. Mesol, a basic-helix-loop-helix protein involved in mammalian presomitic mesoderrn development. Pro(. Natl. Acad. Sei. U.S. A. 92: 5870-5874.
103. Blaugrund, E., T. D. Pham, V. M. Tennyson, L. Lo, L. Sommer, D. J. Anderson, and M. D. Gershon. 1996. Distinct subpopulations of enteric neuronal progenitors defined by time of development, sympathoadrenal lineage markers and Mash-1-dependence. Development. 122: 309-320.
104. Blyth, K., A. Terry, M. O'Hara, E. W. Baxter, M. Campbell, M. Stewart, L. A. Donehower, D. E. Onions, J. C. Neu, and E. R. Cameron. 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Qncogene. 10: 1717-1723.
105. Bock, K. W. 1994. Aryl hydrocarbon or dioxin receptor: biologic aid toxic responses. Ren. Physiol. Biochem. Pharmacol. 125: 1-42.
106. Bockamp, E. O., V. McLaughlin, A. M. Murrell, B. Gottgens, L. Robb, C. G. Begley, and A. R. Green. 1995. Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood. 86: 1502-1514.
107. 1400. Bodrug, S. E., B. J. Warner, M. L. Bath, G. J. Lindeman, A. W. Harris, and J. M. Adams.
108. Cyclin Dl transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMKO J. 13: 2124-2130.
109. Bogenmann, E., M. Torres, and H. Matsushima. 1995. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation. Oncogene. 10: 1915-1925.
110. Boguski, M. S., A. Bairoch, T. K. Attwood, and G. S. Michaels. 1992. Proto-vav and gene expression. Nature 358: 113.
111. Bolufer, P., R. Molina, A. Ruiz, M. Hernandez, C. Vazquez, and A. Lluch. 1994. Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer. Clin. Chim. Ada 229: 107-122.
112. Bonven, B. J., A. L. Nielsen, P. L. Norby, F. S. Pedersen, and P. Jorgensen. 1995. E-box variants direct formation of distinct complexes with the basic helix-loop-helix protein ALF1. J. Mol. biol. 249: 564-575.
113. Bordow, S. B., M. Haber, J. Madafiglio, B. Cheung, G. M. Marshall, and M. D. Norris. 1994. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 54: 5035-5040.
114. Borkowski, O. M., N. H. Brown, and M. Bate. 1995. Anterior-posterior subdivision and the diversification of the mesoderm in Urosophila. Development. 121: 4183-4193.
115. Brand, M., A. P. Jarman, L. Y. Jan, and Y. N. Jan. 1993. asense is a Drosophila neural precursor gene and is capable of initiating sense organ formation, Development. 119: 1-17.
116. Braun, T. and H. -H. Arnold. 1996. myf-S and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO. J. 15: 310-318.
117. Braun, T. and H. H. Arnold. 1994. ES-cells carrying two inactivated myf-S alleles form skeletal muscle cells: activation of an alternative myf-5-independent differentiation pathway. Dev. biol. 164: 24-36.
118. Braun, T. and H. H. Arnold. 1995. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14: 1176-1186.
119. Braun, T., E. Bober, M. A. Rudnicki, R. Jaenisch, and H. H. Arnold. 1994. MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. Development. 120: 3083-3092.
120. Brennscheidt, U., D. Eick, R. Kunzmann, U. Martens, M. Kiehntopf, R. Mertelsmann, and F. Herrmann. 1994. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia. Leukemia 8: 897-902.
121. Breuer, B., I. DeVivo, J. C. Luo, S. Smith, M. R. Pincus, A. H. Tatum, J. Daucher, C. R. Minick, D. G. Miller, E. J. Nowak et al. 1994. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients. Cancer Epidemiol. Eiomarkers. Prev. 3: 63-66.
122. Brough, D. E., T. J. Hofmann, K. B. Ellwood, R. A. Townley, and M. D. Cole. 1995. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for ElA-mediated transformation. Mol. Cell Biol. 15: 1536-1544.
123. Brown, N. L., C. A. Sattler, S. W. Paddock, and S. B. Carroll. 1995. Hairy and emc negatively regulate morphogenetic furrow progression in the Drosophila eye. Cell. 80: 879-887.
124. Brys, A. and N. Maizels. 1994. LR1 regulates c-myc transcription in B-cell lymphomas. Proc. NatJ. Acad. Sei. U. X. A. 91: 4915-4919.
125. Bungert, J., I. Kober, F. During, and K. H. Seifart. 1992. Transcription factor eUSF is an essential component of isolated transcription complexes on the duck histone H5 gene and it mediates the interaction of TFIID with a TATA-deficiem promoter J. mol. Biol. 223: 885-898. [Published erratum appears in 1992. J. Mol. Biol. 227:978.]
126. Burgess, R., P. Cserjesi, K. L. Ligon, and E. N. Olson. 1995. Paraxis: a basic helix-loop- helix protein expressed in paraxial mesoderm and developing somites. Dev. biol. 168: 296-306.
127. Burgess, T. L., E. F. Fisher, S. L. Ross, J. V. Bready, Y. X. Qian, L. A. Bayewitch, A. M. Cohen, C. J. Herrera, S. S. Hu, T. B. Kramer et al. 1995. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. NatJ. Acad. Sei. U. .S. A. 92: 4051-4055.
128. Bustelo, X. R., S. D. Rubin, K. L. Suen, D. Carrasco, and M. Barbacid. 1993. Developmental expression of the vav protooncogene. Cell Growth. Differ. 4: 297-308.
129. Butterworth, B. E., C. S. Sprankle, S. M. Golds-worthy, D. M. Wilson, and T. L. Goldsworthy. 1994. Expression of myc, fos, and Ha-ras in the livers of furan-treated F344 rats and B6C3F1 mice. Mol. Carcinog. 9: 24-32.
130. Cameron, E. R., M. Campbell, K. Blyth, S.A. Argyle, L. Keanie, J. C. Neil, and D. E. Onions. 1996. Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice. Br. J. Cancer 73: 13-17.
131. Campos Ortega, J. A. 1995. Genetic mechanisms of early neurogenesis in Drosophila melanogaster. Mol. Neurobiol. 10: 75-89.
132. Carmena, A., M. Bate, and F. Jimenez. 1995. Lethal of scute, a proneural gene, participates in the specification of muscle progenitors during Drosophila embryogenesis. Genes. Dev. 9: 2373-2383.
133. Carney, M. E., R. C. O'Reilly, B. Sholevar, O. I. Buiakova, L. D. Lowry, W. M. Keane, F. L. Margolis, and J. L. Rothstein. 1995. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J. Neurooncol. 26: 35-43.
134. Carrier, F., C. Y. Chang, J. L. Duh, D. W. Nebert, and A. Puga. 1994. Interaction of the regulatory domains of the murine Cyplal gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Biochem. Pbarmacol. 48: 1767-1778.
135. Carver, L. A., V. Jackiw, and C. A. Bradfield. 1994. The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J. biol. Chem. 269: 30109-30112.
136. Castresana, J. S., C. Barrios, L. Gomez, and A. Kreicbergs. 1994. No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis. Cancer Genet. Cjtogenet. 76: 47-49.
137. Chakrabarti, D., S. Mukhopadhyay, and A. K. Duttagupta. 1995. A novel genetic interaction between daughterless and a variegating rearrangement strain of Drosophila melanogaster. Genome. 38: 105-111.
138. Chan, W. K., R. Chu, S. Jain, J. K. Reddy, and C. A. Bradfield. 1994. Baculovirus expression of the Ah receptor and Ah receptor nuclear translocater. Evidence for additional dioxin responsive element-binding species and factors required for signaling. J. Biol. Cher. 269: 26464-26471.
139. Chang, H., J. A. Blondal, S. Benchimol, M. D. Minden, and H. A. Messner. 1995. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines. Lexk. Lymphoma. 19: 165-171.
140. Chaouchi, N., C. Wallon, J. Taieb, M. T. Auffredou, G. Tertian, F. M. Lemoine, J. F. Delfraissy, and A. Vazquez. 1994. Interferon-a-mediated prévention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc. Clin. Immunol. Immunopathol. 73: 197-204.
141. Chattopadhyay, P., M. Banerjee, C. Sarkar, M. Mathur, A. K. Mohapatra, and S. Sinha. 1995. Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells. Oncogene. 11: 2711-2714.
142. Chaudhary, D. and D. M. Miller. 1995. The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter, biochemistry 34: 3438-3445.
143. Chavany, C., Y. Connell, and L. Neckers. 1995. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Mol. Pharmacol. 48: 738-746.
144. Chen, C. H., J. Zhang, and C. C. Ling. 1994. Transfected c-myc and c-Ha-ras modulate radiationinduced apoptosis in rat embryo cells. Radiât. Res. 139: 307-315.
145. Chen, H., B. Li, and J. L. Workman. 1994. A histone-binding protein, nucleoplasmin, stimulates transcription factor binding to nucleosomes and factorinduced nucleosome disassembly. EMBO J. 13: 380-390.
146. Chen, J., T. Liu, and A. H. Ross. 1994. Downregulation of c-myc oncogene during NGF-induced differentiation of neuroblastoma cell lines. Chin. Med. Sei.]. 9: 152-156.
147. Chen, J., T. Willingham, L. R. Margraf, N. Schreiber Agus, R. A. DePinho, and P. D. Nisen. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat. Med. 1: 638-643.
148. Chen, L., M. Krause, M. Sepanski, and A. Fire. 1994. The Caenorhabditis elegans MYOD homologue HLH-1 is essential for proper muscle function and complete morphogenesis. Development. 120: 1631 -1641.
149. Cheng, J. M., J. L. Hiemstra, S. S. Schneider, B. A. Kaufman, A. Naumova, N. K. Cheung, S. L. Cohn, L. Diller, C. Sapienza, and G. M. Brodeur. 1994. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Prog. Clin. Biol. Res. 385: 43-49.
150. Cheng, N. C., N. Van Roy, A. Chan, M. Beitsma, A. Westerveld, F. Speleman, and R. Versteeg. 1995. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the Ip35-36 region, only one of which is associated with N-myc amplification. Oncogene. 10: 291-297.
151. Cherney, B. W., K. Bhatia, and G. Tosato. 1994. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sei. U. S. A 91: 12967-12971.
152. Chetty, R., L. Cerroni, K. Pulford, A. Giatromanolaki, S. Biddolph, L. Kaklamanis, and K. Gatter. 1995. TALI gene deletions and TALI protein expression in sporadic melanoma. Melanoma. Res. 5: 251-254.
153. Chetty, R., K. Pulford, M. Jones, D. Mathieu Mahul, P. Close, S. Hussein, G. Pallesen, E. Ralfkiaer, H. Stein, K. Gatter et al. 1995. SCL/Tal-1 expression in T-acute lymphobkstic leukemia: an immunohistochemical and genotypic study. Ham. Pathol. 26: 994-998.
154. Chieffi, P., S. Minucci, G. Cobellis, S. Fasano, and R. Pierantoni. 19')5. Changes in proto-oncogene activity in the testi s of the frog, Kana esculenta, during the annual reproductive cycle. Gen. Comp. Endocrinol. 99: 127-136.
155. Chien, C. H., F. F. Wang, and T. C. Hamilton. 1994. Transcriptional activation of c-myc proto-oncogene by estrogen in humar ovarian cancer cells. Mol. Cell Endocrinol. 99: 11-19.
156. Chin, L., N. Schreiber Agus, I. Pellicer, K. Chen, H. W. Lee, M. Dudast, C. Cordon Cardo, and R. A. DePinho. 1995. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sei. U.S. A. 92: 8488-8492.
157. Chou, T. Y., G. W. Hart, and C. V. Dang. 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270: 18961-18965.
158. Christiansen, H., O. Delattre, S. Fuchs, M. Theobald, N. M. Christiansen, F. Berthold, and F. Lampert. 1994. Loss of the putative tumor suppressor-gene locus Ip36 as investigated by a PCRassay and N-myc amplification in 48 neuroblastomas: results of the Ger nan Neuroblastoma Study Group. Prog. Clin. biol. R?s. 385: 19-25.
159. Chu, E., T. Takechi, K. L. Jones, D. M. Voeller, S. M. Copur, G. F. Maley, F. Maley, S. Segal, and C. J. Allegra. 1995. Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol. Cell Biol. 15: 179-185.
160. Clark, H. M., T. Yano, T. Otsuki, E. S. Jaffe, D. Shibata, and M. Raffeld. 1994. Mutations in thé coding region of :-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res. 54: 3383-3386.
161. Clevenger, C. V., W. Ngo, D. L. Sokol, S. M. Luger, and A. M. Gewirtz. 1995. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chew. 270: 13246-13253.
162. Cogswell, J. P., M. M. Godlevski, M. Bonham, J. Bisi, and L. Babiss. 1995. Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin Bl gene promoter. Mol. Cell Biol. 15: 2782-2790.
163. Cohn, S. L., A. T. Look, V. V. Joshi, T. Holbrook, H. Salwen, D. Chagnovich, L. Chesler, S. T. Rowe, M. B. Valentine, H. Komuro et al. 1995. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pédiatrie Oncology Group study. Cancer Res. 55: 721-726.
164. Collins, V. P. 1995. Gene amplification in human gliomas. Glia. 15: 289-296.
165. Combaret, V., N. Gross, C. Lasset, D. Frappaz, G. Peruisseau, T. Philip, D. Beck, and M. C. Favrot. 1996. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pédiatrie neuroblastomas. J. Clin. Oncol. 14: 25-34.
166. Consonni, G., F. Geuna, G. Gavazzi, and C. Tonelli. 1993. Molecular
167. Consonni, G., A. Viotti, S. L. Dellaporta, and C. Tonelli. 1992. cDNA nucleotide sequence of Sn, a regulatory gene in maize. Nucleic Acids Res. 20: 373.
168. Contegiacomo, A., C. Pizzi, L. De Marchis, M. Alimandi, P. Delrio, E. Di Palma, G. Petrella, L. Ottini, D. French, L. Frati et al. 1995. High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers. Int. J. Cancer 61: 1-6.
169. Coppola, J., S, Bryant, T. Koda, D. Conway, and M. Barbacid. 1991. Mechanism of activation of the vav protooncogene. Cell Growth. Differ. 2: 95-105.
170. Corbo, L., F. Le Roux, and A. Sergeant. 1994. The EBV early gene product EB2 transforms rodent cells through a signalling pathway involving c-Myc. Oncogene. 9: 3299-3304.
171. Corvi, R., L. Savelyeva, L. Amier, R. Handgretinger, and M. Schwab. 1995. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line. Eur. J. Cancer 31A: 520-523.
172. Corvi, R., L. Savelyeva, and M. Schwab. 1995. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res. 55: 3471-3474.
173. Coumailleau, P., L. Poellinger, J. A. Gustafsson, and M. L. Whitelaw. 1995. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. J. Biol. Chem. 270: 25291-25300.
174. Cowley, C. G., W. L. Carroll, and J. M. Johnston. 1996. The absence of ongoing immunoglobulin gene hypermutation suggests a distinct mechanism for c-myc mutation in endemic Burkitt's lymphoma. J. Pediatr. Hematol. Oncol. 18: 29-35.
175. Crescenzi, M., D. H. Crouch, and F. Tato. 1994. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J. Cell biol. 125: 1137-1145.
176. Cross, J. C., M. L. Flannery, M. A. Blanar, E. Steingrimsson, N. A. Jenkins, N. G. Copeland, W. J. Rutter, and Z. Werb. 1995. Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development. 121: 2513-2523.
177. Cserjesi, P., D. Brown, K. L. Ligon, G. E. Lyons, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and E. N. Olson. 1995. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development. 121: 1099-1110.
178. Cserjesi, P., D. Brown, G. E. Lyons, and E. N. Olson. 1995. Expression of the novel basic helix-loop-helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev. Biol. 170: 664-678.
179. Cutrona, G., M. Ulivi, F. Fais, S. Roncella, and M. Ferrarini. 1995. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J. Exp. Med. 181: 699-711.
180. Dajani, O. F., M. Refsnes, T. K. Guren, R. S. Horn, G. H. Thoresen, and T. Christoffersen. 1994. Elevated glucose concentrations inhibit DNA synthesis and expression of c-myc in cultured hepatocytes. Biochem. Biophys. Res. Commun. 202: 1476-1482.
181. Daksis, J. I., R. Y. Lu, L. M. Facchini, W. W. Marhin, and L. J. Penn. 1994. Myc induces cyclin Dl expression in thé absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene. 9: 3635-3645.
182. Damiani, R. D. J. and S. R. Wessier. 1993. An upstream open reading frame represses expression of Lc, a member of the R/B family of maize transcriptional activators. Prof. Natl. Acad. Sei. U. S. A. 90: 8244-8248.
183. Datta, P. K., A. K. Ghosh, and S. T. Jacob. 1995. The RNA polymerase I promoter-activating factor CPBF is functionally and immunologically related to the basic helix-loop-helix-zipper DNA-binding protein USF. J. Biol. Chem. 270: 8637-8641.
184. Davidoff, A. N. and B. V. Mendelow. 1994. Protein synthesis inhibition is not a requisite for puromycin- and cycloheximide-induced c-myc mRNA superinduction. Anticancer. Res. 14: 1199-1201.
185. Dawson, S. R., D. L. Turner, H. Weintraub, and S. M. Parkhurst. 1995. Specificity for the hairy/enhancer of split basic helix-loop-helix (bHLH) proteins maps outside the bHLH domain and suggests two separable modes of transcriptional repression. Mol. CellBiol. 15: 6923-6931.
186. de Celis, J. F., A. Baonza, and A. Garcia Bellido. 1995. Behavior of extramacrochaetae mutant cells in the morphogenesis of the Drosophila wing. Mech. Dev. 53: 209-221.
187. de Celis, J. F., A. Garcia Bellido, and S. J. Bray. 1996. Activation and function of Notch at the dorsal-ventral boundary of the wing imaginai disc. Development. 122: 359-369.
188. De Winde, J. H. and L. A. Grivell. 1995. Regulation of mitochondria! biogenesis in Saccharomyces cerevisiae. Intricate interplay between general and specific transcription factors in the promoter of the QCR8 gene. Ear. J. Biochem. 233: 200-208.
189. Deed, R. W., M. Jasiok, and J. D. Norton. 1994. Nucleotide sequence of the cDNA encoding human helix-loop-helix Id-1 protein: identification of functionally conserved residues common to Id proteins. Biochim. Biophys. Acta 1219: 160-162.
190. Deguchi, T. and H. C. Pilot. 1995. Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phénobarbital. Mol. Carcinog. 14: 152-159.
191. Delgado, M. D., A. Lerga, M. Canelles, M. T. Gomez Casares, and J. Leon. 1995. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene. 10: 1659-1665.
192. Deltour, L., P. Leduque, N. Blume, O. Madsen, P. Dubois, J. Jami, and D. Bucchini. 1993. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Prof. Nail. Acad. Sei. U. S. A. 90: 527-531.
193. Denis, N., S. Blanc, M. P. Leibovitch, N. Nicolaiew, F. Dautry, M. Raymond Jean, J. Kfuh, and A. Kitzis. 1987. c-myc oncogene expression inhibits the initiation of myogenic differentiation. Exp. Cell. Res. 172: 212-217.
194. Desbarats, L., S. Gaubatz, and M. Eilers. 1996. Discrimination between different E-box-binding proteins at an endogenous target gene of c-mjc. Genes. Dev. 10: 447-460.
195. Desprez, P. Y., E. Hara, M. J. Bissell, and J. Campisi. 1995. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. CellBiol. 15: 3398-3404.
196. Dewanjee, M. K., A. K. Ghafouripour, M. Kapadvanjwala, S. Dewanjee, A. N. Serafini, D. M. Lopez, and G. N. Sfakianakis. 1994. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. NutJ. MetJ. 35: 1054-1063.
197. Dewanjee, M. K., A. K. Ghafouripour, M. Kapadvanjwala, and A. T. Samy. 1994. Ivinetics of hybridization of niRNA of c-myc oncogene with In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography. Biotethniqaes. 16: 844-6, 848, 850.
198. Di Fagagna, F. D., G. Matzio, M. I. Gutierrez, L. Y. Kang, A. Falaschi, and M. Giacca. 1995. Molecular and funct onal interactions of transcription factor USF with the long terminal repeat ot human immunodeficiency v rus type 1. J. l'irol. 69: 2765-2775.
199. Diaz Guerra, M. J., M. O. Bergot, A. Martinez, M. H. Cuif, A. Kahn, and M. Raymondjean. 1993. Functional characterization ot the L-type pvruvate kinase gene glucose response complex. Mol. Cell RioJ. 13: 7725-7733.
200. Djondjurov, L. P., M. M. Andreeva, D. Z. Markova, and R. M. Donev. 1994. Spatial and structural segregation of the transcribed and nontranscribed alleles of c-myc in Namalvi-S cells. Oncol. Res. 6: 347 -356.
201. Dolwick, K. M., H. I. Swanson, and C. A. Bradfield. 1993. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Prnc. NatJ. Acad. Sci. U. .V. A. 90: 8566-8570.
202. Dooley, S., I. Wundrack, N. Blin, and C. Welter. 1995. Coexprcssion Dauern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription. Riochtw. ïïifiphys. Ko\ (.owmitn. 213: 789-795.
203. Dorsman, J. C., A. Gozdzicka Jozefiak, W. C. van Heeswijk, and L. A.. Grivell. 1991. Multi-functional DNA proteins in ytast: the factors GFI and GFII are identical to the ARS-binding factor ABFI and the centromere-binding factor CPF1 respectively. Yeu.tt. 7: 401-412.
204. Dosaka Akita, H., K. Akie, H. Hiroumi, I. Kinoshita, Y. Kawakami, and A. Murakami. 1995. Inhibition of proliferation by L-myc antisense DNA for the translational ini'iation site in human small cell lung cancer. Cancer Res. 55: 1559-1564.
205. Dowell, S. J., J. S. Tsang, and J. Mellor. 1992. The centromere and promoter factor 1 of yeast contains a dimerisation domain located carboxy-terminal to the bHLH domain. Nucleic Acids Res. 20: 4229-4236.
206. Downes, M., L. Mynett Johnson, and G. E. Muscat. 1994. The retinoic icid and retinoid X receptors are differentially expressed during myoblast differentiation. EndocrinohQ' 134: 2658-2661.
207. Duivenvoorden, W. C., R. Schafer, A. M. Pfeifer, D. Piquet, and P. Maier. 1995. Nuclear matrix condensation and c-myc and c-fos expression are specifically altered in culture rat hepatocytes after exposure to cyproterone acetate and phénobarbital. Biof/jefx. Riophys. Res. Commun. 215: 598-605.
208. Duncan, M. K., T. Shimamura, and K. Chada. 1994. Expression of the helix-loop-helix protein, Id, during branching morphogenesis in the kidney. Kidney. Int. 46: 324-332.
209. Eagle, L. R., X. Yin, A. R. Brothman, B. J. Williams, N. B. Atkin, and E. V. Prochownik. 1995. Mutation of the AJ.V/7 gene in prostate cancer. -4\at: Genet. 9: 249-255.
210. Eckhardt, S. G., A. Dai, K. K. Davidson, B. J. Forseth, G. M. Wahl, and D. D. Von Hoff. 1994. Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proc. \citl. /\cad. Set. !J. .V. A. 91: 6674-6678.
211. Edelman, E. R., M. Simons, M. G. Sirois, and R. D. Rosenberg. 1995. c-myc in vasculoproliferative disease. Cm. Res. 76: 176-182.
212. Edmondson, D. G. and E. N. Olson. 1989. A gene with homology to the myc similarity region ot MyoDl is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes. Dei1. 3: 628 -640. [Published erratum appears in 1990. Genes Dei: 4:1450.]
213. Einarson, M. B. and M. V. Chao. 1995. Regulation of Idl and its association with basic helix-loop-helix proteins during nerve growth factor-induced differentiation of PC12 cells. A/J. Celt biol. 15: 4175-4183.
214. Elferink, C. J. and J. P. J. Whitlock. 1994. Dioxin-dependent, DNA sequence-specific binding of a multiprotein complex containing the Ah receptor. Receptor. 4: 157-173.
215. Eliopoulos, A. G., D. J. Kerr, H. R. Maurer, P. Hilgard, and D. A. Spandidos. 1995. Induction of the c-myc but not the cH-ras promoter by platinum compounds. Wiocbem. Pharmacol. 50: 33 -38.
216. Ellis, H. M. 1994. Embryonic expression and function of the Drosophila helix -loop-helix gene, extramacrochaetae. Much. Dei: 47: 65 -72.
217. Ellis, H. M., D. R. Spann, and J. W. Posakony. 1990. extramacrochaetae, a negative regulator of sensory organ development in Drosophila, defines a new class of helix -loop -heiix proteins. Cc//61: 27-38.
218. Ellmeier, W. and A. Weith. 1995. Expression of the helix -loop -helix gene Id3 during murine embryonic development. Dei: Dyn. 203: 163-173.
219. Elson, A., C. Deng, J. Campos Torres, L. A. Donehower, and P. Leder. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogsne. 11: 181-190.
220. Elwood, N. J. and C. G. Begley. 1995. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia. Cell Growth. Differ. 6: 19-25.
221. Elwood, N. J., W. D. Cook, D. Metcalf, and C. G. Begley. 1993. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine Tlymphocyte cell line. Oncogens. 8: 3093-3101.
222. Elwood, N. J., A. R. Green, A. Melder, C. G. Begley, and N. Nicola. 1994. The SCL protein displays cellspecific heterogeneity in size. Leukemia 8: 106-114.
223. Ema, M., M. Suzuki, M. Morita, K. Hirose, K. Sogawa, Y. Matsuda, O. Gotoh, Y. Saijoh, H. Fujii, H. Hamada, and Y. Fujii Kuriyama. 1996. cDNA cloning of a murine homologue of Drosophila single-minded, its mRNA expression in mouse development, and chromosome localization. Biochem. Biopbys. Res. Commun. 218: 588-594.
224. Emery, J. F. and E. Bier. 1995. Specificity of CNS and PNS regulatory subelements comprising pan-neural enhancers of the deadpan and scratch genes is achieved by repression. Development. 121: 3549-3560.
225. Enan, E. and F. Matsumura. 1995. Evidence for a second pathway in the action mechanism of 2,3,7,8tetrachlorodibenzo-/j-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49: 249-261.
226. Ericsson, J., S. M. Jackson, B. C. Lee, and P. A. Edwards. 1996. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc. Natl. Acad. Sci. U. S. A. 93: 945-950.
227. Ernst, C. W., D. A. Vaske, R. G. Larson, M. E. White, and M. F. Rothschild. 1994. Rapid communication: Mspl restriction fragment length polymorphism at the swine MYF6 locus. J. Anita. Sci. 72: 799.
228. Evans, S. M., W. Yan, M. P. Murillo, J. Ponce, and N. Papalopulu. 1995. tinman, a Drosophila homeobox gene required for heart and visceral mesoderm specification, may be represented by a family of genes in vertebrates: XNkx-2.3, a second vertebrate homologue of tinman. Development. 121: 3889-3899.
229. Fegan, C. D., D. White, and M. Sweeney. 1995. C-myc amplification, double minutes and homogenous staining regions in a case of AML. Br. J. Haematol. 90: 486-488.
230. Feinman, R., W. Q. Qiu, R. N. Pearse, B. S. Nikolajczyk, R. Sen, M. Sheffery, and J. V. Ravetch. 1994. PU.l and an HLH family member contribute to the myeloid-specific transcription of the Fc 7 RIIIA promoter. EMBO J. 13: 3852-3860.
231. Fernandez, A., M. C. Marin, T. McDonnell, and H. N. Ananthaswamy. 1994. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese Superoxide dismutase in resistant cells. Oncogene. 9: 2009-2017.
232. Finnegan, M. C., D. W. Hammond, B. W. Hancock, and M. H. Goyns. 1995. Activation of MYCN in a case of non-Hodgkin's lymphoma. Leuk. Lymphoma. 18: 511-514.
233. + thymocytes. Nature 374: 474-477.
234. Fisher, A. L., S. Ohsako, and M. Caudy. 1996. The WRPW motif of the Hairy-related proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain. Mol. Cell. Eiol. 16: 2670-2677.
235. Flickinger, K. S., R. Judware, R. Lechner, W. G. Carter, and L. A. Culp. 1994. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors. Exp. Cell Res. 213: 156-163.
236. Floss, T., H. -H. Arnold, and T. Braun. 1996. Myf5ml/Myf-6ml compound heterozygous mouse mutants down-regulate Myf-5 expression and exert rib defects: evidence for long-range cis effects on Myc-5 transcription. Dev. Biol. 174: 140-147.
237. Fodor, E., S. L. Weinrich, A. Meister, N. Mermod, and W. J. Rutter. 1991. A pancreatic exocrine cell factor and AP4 bind overlapping sites in the amylase 2A enhancer. Biochemistry 30: 8102-8108.
238. Fornari, F. A. J., W. D. Jarvis, S. Grant, M. S. Orr, J. K. Randolph, F. K. White, V. R. Mumaw, E. T. Lovings, R. H. Freeman, and D. A. Gewirtz. 1994. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth. Differ. 5: 723-733.
239. Fraser, H. M., S. F. Lunn, G. M. Cowen, and P. J. Illingworth. 1995. Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. J. Endocrinol. 147: 131-137.
240. Frazier, K. S., M. E. Hines, A. I. Hurvitz, P. G. Robinson, and A. J. Herron. 1993. Analysis of DNA aneuploidy and c-myc oncoprotein content of canine plasma cell tumors using flow cytometry. Vet. Pathol. 30: 505-511.
241. Frost, G. H., K. Rhee, T. Ma, and E. A. Thompson. 1994. Expression of e-Myc in glucocorticoid-treated fibroblasticcells.J. Steroid. Biochem. Mol. Eiol. 50:109-119.
242. Fuchtbauer, E. M. 1995. Expression of M-twist during postimplantation development of the mouse. Den. Dyn. 204: 316-322.
243. Fujii Kuriyama, Y., M. Erna, J. Mimura, N. Matsushita, and K. Sogawa. 1995. Polymorphic forms of the Ah receptor and induction of the CYP1 Al gene. Pharmacogemtus. 5 Spec No:S149-S153.
244. Fujii Kuriyama, Y., M. Erna, J. Mimura, and K. Sogawa. 1994. Ah receptor: a novel ligand-activated transcription factor Exp. Clin, \mmunogenet. 11: 65-74.
245. Fujimoto, J., M. Hori, S. Ichigo, M. Nishigaki, and T. Tamaya. 1994. Tissue differences in the expression of mRNAs of Ha-ris, c-myc, fos and jun in human uterine endometriu n, myometrium and leiomyoma under the influence of estrogen/progesterone. Tumour. Biol. 15: 311-317.
246. Fukamizu, A., M. Sagara, F. Sugiyama, H. Horiguchi, H. Kamma, T. Hatae, T. Ogata, K. Yagami, and K Murakami. 1994. Neuroectodermal tumors expressing c-, I.-, and N-myc in transgenic mice that carry the El A/ El B gene of human adenovirus type 12. J. biol. Chetn. 269: 31252-31258.
247. Fukunaga, B. N. and O. Hankinson. 1996. Identification of a rovel domain in the aryl hydrocarbon receptor required for DNA binding. J. biol. Chem. 271: 3743-3749.
248. Fukunaga, B. N., M. R. Probst, S. Reisz Porszasz, and O. Hankinson. 1995. Identification of functional domains of the ary' hydrocarbon receptor. J. biol. Chem. 270: 29270-29278
249. Fulton, R., R. Gallagher, D. Crouch, and J. C. Neil. 1996. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced b/ feline leukemia virus. J. I 'irai. 70: 1154-1162.
250. Furihata, C., A. Yamakoshi, A. Hatta, M. Tatematsu, H. Iwata, K. Hayashi, K. Umezawa, and T. Matsushima. 994. Induction of c-fos and c-myc oncogene expression in the pyloric mucosa of rat stomach by /V-methyl-A -nitro-/V-nitrosoguanidme and taurocholate. Cancer Lett. 83: 215-220.
251. Gaffey, M. J., H. F. J. Frierson, and M. E. Williams. 1993. Chromosome Ilql3, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Mod. Pathol. 6. 654-65').
252. Gallagher, R. C., J. C. Neil, and R. Fulton. 1995. Cloning and sequence of the feline max, and max 9 transcripts. DNA Seq. 5: 269-271.
253. Galland, F., S. Katzav, and D. Birnbaum. 1992. The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. Oncogens. 1: 585-587.
254. 1545a. Gallant, P., Shiio, Y., Cheng, P. F., Parkhurst, S. M. and Eisenman, R. N. 1996. Myc and Max homologs in Drosophila. Science 274: 1523-1527.
255. Gandarillas, A. and F. M. Watt. 1995. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Qncogem. 11: 1403 -1407.
256. Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers. 1995. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14: 1508-1519.
257. Gazzeri, S., E. Brambilla, C. Caron de Fromentel, V. Gouyer, D. Moro, P. Perron, F. Berger, and C. Brambilla. 1994. p53 genetic abnormalities and myc activation in human lung carcinoma. Int. J. Cancer 58: 24-32.
258. George Weinstein, M., J. Gerhart, R. Reed, J. Flynn, B. Callihan, M. Mattiacci, C. Miehle, G. Foti, J. W, Lash, and H. Weintraub. 1996. Skeletal myogenesis: the preferred pathway of chick embryo epiblast cells in vitro. Dev. biol. 173: 279-291.
259. Gerber, A. N. and S. J. Tapscott. 1996. Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activity. Mol. Cell. BhJ. 16: 3901 -3908.
260. Gibson, A. W., T. Cheng, and R. N. Johnston. 1995. Apoptosis induced by c-myc overexpression is dependent on growth conditions. Exp. Cell Res. 218: 351 -358.
261. Givol, I., D. Givol, S. Rulong, J. Resau, I. Tsarfaty, and S. H. Hughes. 1995. Overexpression of human p21wafl/cipl arrests the growth of chicken embryo fîbroblasts transformed by individual oncogenes. Oncogene. 11: 2609-2618.
262. Goldfarb, A. N. and J. M. Greenberg. 1994. T cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCI./tal. ]-4euk. Lymphoma. 12: 157-166.
263. Goldfarb, A. N. and K. Lewandowska. 1994. Nuclear redirection of a cytoplasmic helix-loop-helix protein via heterodimerization with a nuclear localizing partner. Exp. Cell. Res. 214: 481-485.
264. Goldfarb, A. N. and K. Lewandowska. 1995. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism. Blood. 85: 465-471.
265. Goldhamer, D. J., B. P. Brunk, A. Faerman, A. King, M. Shani, and C. P. J. Emerson. 1995. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development. 121: 637-649.
266. Goswami, S. K. and M. A. Siddiqui. 1995. Transactivation of cardiac MLC-2 promoter by MyoD in lOTl/2 fibroblast cells is independent of E-box requirement but depends upon new proteins that recognize MEF-2 site. Cell Mol. biol. Res. 41: 199-205.
267. Gradin, K., R. Toftgard, and A. Berghard. 1995. Differential effects of a topoisomerase I inhibitor on dioxin inducibility and high-level expression of the cytochrome P450IA1 gene. Mol. Pbarmacol. 48: 610-615.
268. Gradin, K., M. L. Whitelaw, R. Toftgard, L. Poellinger, and A. Berghard. 1994. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. biol. Cher. 269: 23800-23807.
269. Grass, S., H. H. Arnold, and T. Braun. 1996. Alterations in somite patterning of Myf-5-deficient mice:a possible role for FGF-4 and FGF-6. Development. 122: 141-150.
270. 2D3 control of C-cell-carcinoma proliferation. Kochern. Biophys. Res. Commun. 213: 922-927.
271. Gray, I. C., S. M. Phillips, S. J. Lee, J. P. Neoptolemos, J. Weissenbach, and N. K. Spurr. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55: 4800-4803.
272. Greene, D. R., S. R. Taylor, M. Aihara, K. Yoshida, S. Egawa, S. H. Park, T. L. Timme, G. Yang, P. T. Scardino, and T. C. Thompson. 1995. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer. Int. J. Cancer 60: 395-399.
273. Grens, A., E. Mason, J. L. Marsh, and H. R. Bode. 1995. Evolutionary conservation of a cell fate specification gene: the Hydra achaete-scute homolog has proneural activity in Drosophila. Development. 121: 4027-4035.
274. Griffioen, M., L. T. Peltenburg, D. A. van Oorschot, and P. I. Schrier. 1995. C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically. Immunobiology 193: 238-247.
275. Gromova, 1.1., B. Thomsen, and S. V. Razin. 1995. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-saltextracted nuclei. Prof. Natl. Acad. Sci. U. S. A. 92: 102-106.
276. Guillemot, F. 1995. Analysis of the role of basic-helix-loop-helix transcription factors in the development of neural lineages in the mouse. biol. Cell 84: 3-6.
277. Guillemot, F., A. Nagy, A. Auerbach, J. Rossant, and A. L. Joyner. 1994. Essential role of Mash-2 in extraembryonic development. Nature 371: 333-336.
278. Gulbins, E., K. Schlottmann, B. Brenner, F. Lang, and K. M. Coggeshall. 1995. Molecular analysis of Ras activation by tyrosine phosphorylated Vav. Biochem. Biophys. Res. Commun. 217: 876-885.
279. Gundersen, K., I. Rabben, B. J. Klocke, and J. P. Merlie. 1995. Overexpression of myogenin in muscles of transgenic mice:interaction with Id-1, negative crossregulation of myogenic factors, and induction of extrasynaptic acetylcholine receptor expression. Mol. Cell biol. 15: 7127-7134.
280. Guo, K., J. Wang, V. Andres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. biol. IS: 3823-3829.
281. Hale, T. K. and A. W. Braithwaite. 1995. Identification of an upstream region of the mouse p53 promoter critical for transcriptional expression. Nucleic Acids Res. 23: 663-669.
282. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
283. Halle, J. P., C. Schmidt, and G. Adam. 1995. Changes of the methylation pattern of the c-myc gene during in vitro aging of IMR90 human embryonic fibroblasts. Mutât. Res. 316: 157-171.
284. Halle, J. P., G. Stelzer, A. Goppelt, and M. Meisterernst. 1995. Activation of transcription by recombinant upstream stimulatory factor 1 is mediated by a novel positive cofactor. J. biol. Chem. 270: 21307-21311.
285. Hann, S. R. 1994. Regulation and function of nonAUG-initiated proto-oncogenes. Biochimie. 76: 880-886.
286. Hann, S. R. 1995. Methionine deprivation regulates the translation of functionally-distinct c-Myc proteins. Adv. Exp. Med. Biol. 375: 107-116.
287. Hann, S. R., M. Dixit, R. C. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes. Dev. 8: 2441-2452.
288. Harlow, S. P. and C. C. Stewart. 1993. Quantitation of c-myc gene amplification by a competitive PCR assay system. PCR. Methods Appl. 3: 163-168.
289. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295.
290. Harris, L. J., K. Currie, and V. L. Chandler. 1994. Large tandem duplication associated with a Mu2 insertion in Zea mays B-Peru gene, fiant. Mol. Biol. 25: 817-828.
291. Hartley, D. A., A. Preiss, and S. Artavanis Tsakonas. 1988. A deduced gene product from the Drosophila neurogenic locus, enhancer of split, shows homology to mammalian G-protein βsubunit. Cell. 55: 785-795.
292. Harvey, W. H., O. S. Harb, S. T. Kosak, J. C. Sheaffer, L. R. Lowe, and N. A. Heerema. 1994. Interferon-a2b downregulatior of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade, l-4euk. Res. 18: 577-585.
293. Hatton, K. S., K. Mahon, L. Chin, F-C. Chiu, H-W. Lee, D. Peng, S. D. Morgenbesser, J. Horner, and R. A. DePinho. 1996. Expression and activity of L-Myc in normal mouse development. Mol. Cell. Biol. 16: 1794-1804.
294. Hayashi, N. and Y. Oshima. 1991. Specific cis-acting sequence for PHO8 expression interacts with PHO4 protein, a positive regulatory factor, in Saccharomyces cerevisiae. Mol. Cell biol. 11: 785-794.
295. Hayashi, S., J. Okabe Kado, Y. Honma, and K. Kawajiri. 1995. Expression of Ah receptor (TCDD receptor) during ruman monocytic differentiation. Carcinogemsis 16: 1403-1409.
296. Hebrok, M., K. Wertz, and E. M. Fuchtbauer. 1994. M-twist is an inhibitor of muscle differentiation. Dev. biol. 165: 537-544.
297. Heitzler, P., M. Bourouis, L. Ruel, C. Carteret, and P. Simpson. 1996. Genes of the Enhancer of split and achaete-scute complexes are required for a regulatory loop between Notch and Delta during lateral signalling in Drosophila. Development. 122: 161-171.
298. Helms, J. A., S. Kuratani, and G. D. Maxwell. 1994. Cloning and analvsis of a new developmentally regulated membei of the basic helix-loop-helix family. Mecb. Dev. 48: 93-108.
299. Hemmi, H., K. Yamada, U. H. Yoon, M. Kato, F. Taniguchi, Y. Tsuchida, and H. Shimatake. 1995. Coexpression of t le myc gene family members in human neuroblastoma cell lines. Biochem. Mol. biol. Int. 36: 1135-1141.
300. Henrion, A. A., \. Martinez, M. G. Mattel, A. Kahn, and M. Raymondjean. 1995. Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse. Genomics. 25: 36-43.
301. Henske, E. P., M. P. Short, S. Jozwiak, C. M. Bovey, S. Ramlakhan, J. L. Haines, and D. J. Kwiatkowski. 1995. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSG1. Ann. Haw. Genet. 59: 25-37.
302. Henthorn, P. S., C. C. Stewart, T. Kadesch, and J. M. Puck. 1991. The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xpll.22. Genomics. 11: 374-378.
303. Hermeking, H. and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091 -2093.
304. Hermeking, H., J. O. Funk, M. Reichert, J. W. Eilwart, and D. Eick. 1995. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAFl/CIPl/SDIl. Oncogem. 11: 1409-1415.
305. Hermeking, H., D. A. Wolf, F. Kohlhuber A. Dickmanns, M. Billaud, E. Fanning, and D. Eick. 1994. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc. Nail. Acacl. Sci. U. S. A. 91: 10412-10416.
306. Heruth, D. P., L. A. Wetmore, A. Leyva, and P. G. Rothberg. 1995. Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel. J. Cell Kochern. 58: 83-94.
307. Hesketh, J., G. Campbell, M. Piechaczyk, and J. M. Blanchard. 1994. Targeting of c-myc and βglobin coding sequences to cytoskeletal-bound polysomes by c-myc 3' untranslated region. Biochem. J. 298: 143-148.
308. Heufelder, A. E. and R. S. Bahn. 1995. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene. Invest. Ophlhalmol. Vis. Sci. 36: 1420-1432.
309. Hewitt, S. M., S. Hamada, T. J. McDonnell, F. J. Rauscher, and G. F. Saunders. 1995. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res. 55: 5386-5389.
310. Hiemstra, J. L., S. S. Schneider, and G. M. Brodeur. 1994. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas. Prog, Clin. Biol. Res. 385: 51-57.
311. Higuchi, T., H. Kanzaki, M. Fujimoto, H. Hatayama, H. Watanabe, M. Fukumoto, Y. Kaneko, H. Higashitsuji, M. Kishishita, T. Mori et al. 1995. Expression of va v proto-oncogene by nonhematopoietic trophoblast cells at the human uteroplacental interface. Biol. Reprod. 53: 840-846.
312. Hirose, K., M. Morita, M. Ema, J. Mimura, H. Hamada, H. Fujii, Y. Saijo, O. Gotoh, K. Sogawa, and Y. Fujii-Kuriyama. 1996. cDNA cloning and tissue-specific expression of a novel basic helix loopheltx/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arm). Mol. Cell. Rial. 16: 1706-1713.
313. Hirst, K., F, Fishet, P. C. McAndrew, and C. R. Coding. 1994. The transcription factor, the Cdk, its cyclin and their regulator: directing the transcriptional response to a nutritional signal. EMBO J. 13: 5410-5420.
314. Hoang, A. T., B. Luttetbach, B. C. Lewis, T. Yano, T. Y. Chou, J. F. Barren, M. Raffeid, S. R. Hann, and C. V. Dang. 1995. A link between increased transforming activity of lyrnphoma-derived MYC mutant alleles, their defective regulation by p!07, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell Biol. 15: 4031-4042.
315. Hoang, T., E. Paradis, G. Brady, F. Billia, K. Nakahara, N. N. Iscove, and I. R. Kirsch. 1996. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood. 87: 102-111.
316. Hoffman, P. W. and J. M. Chernak. 1995. DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter. Nucleic Acids Res. 23: 2229-2235.
317. Hollenberg, S. M., R. Sternglanz, P. F. Cheng, and H. Weintraub. 1995. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell Biol. 15: 3813-3822.
318. Hoover, R. G., V. Kaushal, C. Lary, P. Travis, and T. Sneed. 1995. c-myc transcription is initiated from P0 in 70% of patients with multiple myeloma. Curr. Top. Microbiol. Immunol. 194: 257-264.
319. Hopewell, R. and E. B. Ziff. 1995. The nerve growth factor-responsive PCI 2 cell line does not express the Myc dimerization partner Max. Mol. Cell Biol. 15: 3470-3478.
320. Hopwood, N. D., A. Pluck, and J. B. Gurdon. 1989. A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest. Cell. 59: 893-903.
321. Hord, N. G. and G. H. Perdew. 1994. Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Mol. Pharmacol. 46: 618-626.
322. Hori, M., R. Kamijo, K. Takeda, and M. Nagumo. 1994. Downregulation of c-myc expression by tumor necrosis factor-a in combination with transforming growth factor-β or interferon-7 with concomitant inhibition of proliferation in human cell lines. J. Interferon. Res. 14: 49-55.
323. Hortnagel, K., J. Mautner, L. J. Strobl, D. A. Wolf, B. Christoph, C. Geltinger, and A. Polack. 1995. The role of immunoglobulin K elements in c-myc activation. Oncogens. 10: 1393-1401.
324. Hortnagel, K., A. Polack, J. Mautner, R. Feederle, and G. W. Bornkamm. 1995. Regulatory elements in the immunoglobulin K locus induce c-myc activation in Burkitt's lymphoma cells. Curr. Top. Microbiol. Immunol. 194:415-422.
325. Hoshizaki, D. K., J. E. Hill, and S. A. Henry. 1990. The Saccharomyces
326. Hovland, R., G. Campbell, I. Pryme, and J. Hesketh. 1995. The mRNAs for cyclin A, c-myc and ribosomal proteins L4 and S6 are associated with cytoskeletal-bound polysomes in HepG2 cells. Biochem. J. 310: 193-196.
327. Hsu, B., M. C. Marin, A. K. el Naggar, L. C. Stephens, S. Brisbay, and T. J. McDonnell. 1995. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene. 11: 175-179.
328. Hu, P., B. Margolis, and J. Schlessinger. 1993. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling. Bioessays 15: 179-183.
329. Huang, W., S. Q. Kuang, Q. H. Huang, S. Dong, T. Zhang, L. J. Gu, L. M. Ching, S. J. Chen, L. C. Chang, and 2. Chen. 1995. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL). Cancer Genet. Cytogenet. 81: 76-82.
330. Huang, Y., R. Snyder, M. Kligshteyn, and E. Wickstrom. 1995. Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Mal. Med. 1: 647-658.
331. Huby, R. D., G. W. Carlile, and S. C. Ley. 1995. Interactions between the protein-tyrosine kinase ZAP-70, the proto-oncoprotein Vav, and tubulin in Jurkat T cells. J. biol. Chem. 270: 30241-30244.
332. Hurlin, P. J., K. P. Foley, D. E. Ayer, R. N. Eisenman, D. Hanahan, and J. M. Arbeit. 1995. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene. 11: 2487-2501.
333. Hurlin, P. J., C. Queva, P. J. Koskinen, E. Steingrimsson, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4:novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO. J. 14: 5646-5659.
334. Huynen, L., J. Bass, R. C. Gardner, and A. R. Bellamy. 1992. Nucleotide sequence of the sheep MyoDl gene. Nucleic. Acids. Res. 20: 374.
335. Ikegaki, N., M. Katsumata, Y. Tsujimoto, A. Nakagawara, and G. M. Brodeur. 1995. Relationship between bcl-2 and myc gene expression in human neuroblastoma. Cancer Lett. 91: 161-168.
336. Imreh, S., Y. Wang, C. K. Panda, M. Babonits, H. Axelson, S. Silva, A. Szeles, F. Wiener, and G. Klein. 1994. Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophagemonocytic tumour line. Eur. J. Cancer 30A: 994-1002.
337. Inagaki, T., S. Matsuwari, R. Takahashi, K. Shimada, K. Fujie, and S. Maeda. 1994. Establishment of human oral-cancer cell lines (KOSC-2 and -3) carrying p! 3 and c-myc abnormalities by geneticin treatmen:. Int. J. Cancer 56: 301-308.
338. Inghirami, G., L. Macri, E. Cesarman, A. Chadburn, J. Zhong, and D. M. Knowles. 1994. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high fiequency of c-myc proto-oncogene activation. Blood. 83: 3581 -3590.
339. Ingvarsson, S., C. Asker, H. Axelson, G. Klein, and J. Sumegi. 1988. Structure and expression of B-myc, a new member of the myc gene family. Moi. Cell, Biol. 8: 3168-3174.
340. Inoue, N., S. Harada, T. Honma, T. Kitamura, and K. Yanagi. 1991. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Virology. 182: 84-93.
341. Isaac, D, D. and I). J. Andrew. 1996. Tubulogenesis in Drosophila: a requirement for the trachealess gene product. Genes. Dtv. 10: 103-117.
342. Ishibashi, M., S. L. Ang, K. Shiota, S. Nakanishi, R. Kageyama, and F. Guillemot. 1995. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes. Den. 9: 3136-3148.
343. Ishida, S., K. Shudo, S. Takada, and K. Koike. 1994. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins. Cell Growth. Differ. 5: 287-294.
344. Ishida, S., K. Shudo, S. Takada, and K. Koike. 1995. A direct role of tianscription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells. Cell Growth. Differ. 6: 229-237.
345. Islas, A. L. and P. C. Hanawalt. 1995. DNA repair in the MYC and FMS proto-oncogenes in ultraviolet lightirradiated human HL60 promyelocytic cells during differentiation. Cancer Res. 55: 336-341.
346. Jackson, S. M., A. Gutierrez Hartmann, and J. P. Hoeffler. 1995. Upstream stimulatory factor, a basic-helix-loop-helix-zipper protein, regulates the activity of the u-g lycoprotein hormone subunit gene in pituitary cells. Mol. Endttcrinol. 9: 278-291.
347. Jacobs El, J., M. Y. Zhou, and B. Russell. 1995. MRF4, Myf-5, and myogenin mRNAs in the adaptive responses of mature rat muscle. Am. J. Physiol. 268:C1045-C1052.
348. Jacobsen, K. A., V. S. Prasad, C. L. Sidman, and D. G. Osmond. 1994. Apoptosis and macrophagemediated deletion of precursor B cells in the bone marrow of E /i-myc transgenic mice. Blood. 84: 2784-2794.
349. Jain, S., K. M. Dolwick, J. V. Schmidt, and C. A. Bradfield. 1994. Potent transactivation domains of the Ah receptor and the Ah receptor nuclear translocator map to their carboxyl termini. J. Bioi. Cher. 269: 31518-31524.
350. Janicke, R. U., F. H. Lee, and A. G. Porter. 1994. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor a in tumor cells. Mol. Cel/Biol. 14: 5661-5670.
351. Janz, S., G. M. Jones, J. R. Muller, and M. Potter. 1995. Genomic instability in B-cells and diversity of recombinations that activate c-myc. Curr. Top. Microbiol. Immunol. 194: 373-380.
352. Jarman, A. P., M. Brand, L. Y. Jan, and Y. N. Jan. 1993. The regulation and function of the helix-loop-helix gene, asense, in Drosophila neural precursors. Development. 119: 19-29.
353. Jarman, A. P., Y. Grau, L. Y. Jan, and Y. N. Jan. 1993. Atonal is a proneural gene that directs chordotonal organ formation in the Drosophila peripheral nervous system. Cell. 73: 1307-1321.
354. Jarman, A. P., E. H. Grell, L. Ackerman, L. Y. Jan, and Y. N. Jan. 1994. Atonal is the proneural gene for Drosophila photoreceptors. Nature. 369: 398-400.
355. Jarriault, S., C. Brou, F. Logeât, E. H. Schroeter, R. Kopan, and A. Israel. 1995. Signalling downstream of activated mammalian Notch. Nature 377: 355 -358.
356. Jeffers, M. D., J. A. Richmond, and E. M. Macaulay. 1995. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas. Mod. Pathol. 8: 701-704.
357. Ji, L., M. Arcinas, and L. M. Boxer. 1994. NF-K B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma. Mot. CellEiol. 14: 7967-7974.
358. 2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma. J. Bioi. Chem. 270: 13392-13398.
359. Johnson, B., B. A. Brooks, C. Heinzmann, A. Diep, T. Mohandas, R. S. Sparkes, H. Reyes, E. Hoffman, E. Lange, R. A. Gatti et al. 1993. The Ah receptor nuclear translocator gene (ARNT) is located on q21 of human chromosome 1 and on mouse chromosome 3 near Cf-3. Getiomics. 17: 592-598.
360. Jones, D. E. J., D. M. Cui, and D. M. Miller. 1995. Expression ofβ-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin. Oncogene. 10: 2323-2330.
361. Jones, G. J., N. S. Heiss, R. B. Veale, and A. L. Thornley. 1993. Amplification and expression of the TGF-a, EGF receptor and c-myc genes in four human oesophageal squamous cell carcinoma lines. Biosci. Rep. 13: 303-312.
362. Judware, R. and L. A. Gulp. 1995. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of /Jj integrin subunit. Oncogene. 11: 2599-2607.
363. Judware, R., R. Lechner, and L. A. Gulp. 1995. Inverse expressions of the N-myc oncogene and /5j integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system. Clin. Exp. Metastasis. 13: 123-133.
364. Kakar, S. S. and D. Roy. 1994. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc protooncogenes messenger RNAs in mouse skin. Cancer Lett. 87: 85-89.
365. Kanavaros, P., D. loannidou, M. Tzardi, G. Datseris, J. Katsantonis, G. Delidis, and A. Tosca. 1994. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol. Res. Pract. 190: 767-774.
366. Kato, J., Y. Kohgo, H. Kondo, K. Sasaki, and Y. Niitsu. 1994. Antisense oligodeoxynucleotides for IL-2, c-myc and transferrin receptor synchronize mitogen-activated lymphocytes in the Gl phase. Scant. J. Immunol. 39: 499-504.
367. Katsaros, D., C. Theillet, P. Zola, G. Louason, B. Sanfilippo, E. Isaia, R. Arisio, G. Giardina, and P. Sismondi. 1995. Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients. Anticancer. Res. 15: 1501-1510.
368. Katzav, S. 1992. vav:a molecule for all haemopoiesis? Br.J. Haematol. 81: 141-144.
369. 2 domain impair the transforming potential of vav and fail to activate proto-vav. Oncogene. 8: 1757-1763.
370. Katzav, S., G. Packham, M. Sutherland, P. Aroca, E. Santos, and J. L. Cleveland. 1995. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene. 11: 1079-1088.
371. Kaushal, S., J. W. Schneider, B. Nadal Ginard, and V. Mahdavi. 1994. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266: 1236-1240.
372. Kawabe, Y., M. Honda, Y. Wada, Y. Yazaki, T. Suzuki, Y. Ohba, H. Nabata, A. Endo, A. Matsumoto, H. Itakura et al. 1994. Stcrol mediated regulation of SREBP-la,lb,lc and SREBP-2 in cultured human cells. Biochem. Biophjs. Res. Commun. 202: 1460-1467.
373. Kazanietz, M. G., X. R. Bustelo, M. Barbacid, W. Kolch, H. Mischak, G. Wong, G. R. Pettit, J. D. Bruns, and P. M. Blumberg. 1994. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C £and the vav and c-raf proto-oncogene products. J. BioL Chem. 269: 11590-11594.
374. Kent, N. A., J. S. Tsang, D. J. Crowther, and J. Mellor. 1994. Chromatin structure modulation in Saccharomyces cerevisiae by centromere and promoter factor 1. Mol. Cell Biol. 14: 5229-5241.
375. Kerkhoff, E. and E. B. Ziff. 1995. Deregulated messenger RNA expression during T cell apoptosis. Nucleic Acids Res. 23: 4857-4863.
376. Khosla, S., M. J. Oursler, M. J. Schroeder, and N. L. Eberhardt. 1994. Transforming growth factor-β, induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels. Endocrinology 135: 1887-1893.
377. Khosravi Far, R., M. Chrzanowska Wodnicka, P. A. Solski, A. Eva, K. Burtidge, and C. J. Der. 1994. Dbl and Vav mediate transformation via mitogenactivated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell Biol. 14: 6848-6857.
378. Kirn, H. G. and D. M. Miller. 1995. Inhibition of;« vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter. Biochemistry 34: 8165-8171.
379. Kim, J. B. and B. M. Spiegelman. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes. Dev. 10: 1096-1107.
380. Kimura, S., T. Maekawa, K. Hirakawa, . Murakami, and T. Abe. 1995. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res. 55: 1379-1384.
381. Kinniburgh, A. J., A. B. Firulli, and R. Kolluri. 1994. DNA triplexes and regulation of the c-myc gene. Gene 149: 93-100.
382. Klefstrom, J., I. Vastrik, E. Saksela, J. Valle, . Eilers, and K. Alitalo. 1994. c-Myc induces cellular susceptibility to the cytotoxic action of TNF-a. EMBOJ. 13: 5442-5450.
383. Klein, G. 1994. Role of EBV and Ig/myc translocation in Burkitt lymphoma. Antibiot. Chemother. 46: 110-116.
384. Kleman, M. I., L. Poellinger, and J. A. Gustafsson. 1994. Regulation of human dioxin receptor function by indolocarbazoles, teceptor ligands of dietary origin. J. biol. Chem. 269: 5137-5144.
385. Ko, H. P., S. T. Okino, Q. Ma, and J. P. J. Whitlock. 1996. Dioxin-induced CYP1A1 transcription in viw.the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structure. Mol, Cell biol. 16: 430-436.
386. Kobayashi, A., K. Sogawa, and Y. Fujii-Kuriyama. 1996. Cooperative interaction between AhR.Arnt and Spl for the drug-ir.ducible expression of CYP1A 1 gene. J. biol. Chem. 271: 12310-12316.
387. Kohlhuber, F., H. Hermeking, A. Graessmann, and D. Eick. 1995. Induction of apoptosis by the c-Myc helix-loop-helix /leucine zipper domain in mouse 3T3-L1 fibroblast;.;. Rial. Chem. 270: 28797-28805.
388. Kokubo, T., R. Takada, S. Yamashita, D. W. Gong, R. G. Roeder, M. Horikoshi, and Y. Nakatani. 1993. Identification of TFID components required for transcriptional activation by upstream stimulatory factor. J. Biol. Chtm. 268: 17554-17558.
389. Koskinen, P. J., D. E. Ayer, and R. N. Eisenman. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell. Growth. Differ. 6: 623-629.
390. Kovacs, D. M., W. Wasco, J. Witherby, K. M. Felsenstein, F. Brunei, R. G. Roeder, and R. E. Tanzi. 1995. The upstream stimulatory factor functionally interacts with the Alzheimer amyloid /iprotein precursor gene. Hum. Mol. Genet. 4: 1527-1533.
391. Kozma, L., I. Kiss, S. Szakall, and I. Ember. 1994. Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Left. 81: 165-169.
392. Krajewski, S., J. Chatten, M. Hanada, and J. C. Reed. 1995. Immunohislochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Lab. Invest. 72: 42-54.
393. Krause, M., A. Fire, S. W. Harrison, J. Priess, and H. Weintraub. 1990. CeMyoD accumulation defines the body wall mi.scle cell fate during (.. tlegans embryogenesis. Cell (A: 907-919.
394. Krause, M., S. W. Harrison, S. Q. Xu, L. Chen, and A. Fire. 1994. Elements regulating cell- and stagespecific expression of the C. elegans MyoD family homolog hlh-1. Dei'. biol. 166: 133-148.
395. Krishnan, V., W. Porter, M. Santostefano, X. Wang, and S. Safe. 1995. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-/)-dioxin (TCDD) in MCF-7 cells. Mol. Cell Biol. 15: 6710-6719.
396. Krupitza, G., R. Pritsche, E. Dittrich, H. Harant, H. Huber, T. Grunt, and C. Dittrich. 1995. Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene. Br. J. Cancer 72: 35-40.
397. Krupitza, G., W. Hulla, H. Harant, E. Dittrich, E. Kallay, H. Huber, T. Grunt, and C. Dittrich. 1995. Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int. J. Cancer 61: 649-657.
398. Kumagai, T., Y. Tanio, T. Osaki, S. Hosoe, I. Tachibana, K. Ueno, T. Kijima, T. Horai, and T. Kishimoto. 1996. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements. Cancer Res. 56: 354-358.
399. Kumakura, S., H. Ishikura, H. Tsumura, H. Hayashi, J. Endo, and T. Tsunematsu. 1994. c-myc protein expression during cell cycle phases in differentiating HL-60 cells. Lenk. L/ympboma. 14: 171-180.
400. Kurabayashi, M., R. Jeyaseelan, and L. Kedes. 1995. Sequences of the 5 -flanking region of the human helix-loop-helix protein-encoding Id2A gene, and promoter activity regulated by serum and c-Jun/AP-1. Gene 156: 311-312.
401. Kwong, Y. L., D. Chan, and R. Liang. 1995. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Cancer Genet. Cytogenet. 85: 159-160.
402. La Gava, A., E. Carbone, A. Moscarella, M. Barcova, S. Salzano, S. Zappacosta, and S. Fontana. 1994. A novel strategy of c-myc oncogene in NK. activity regulation not related to the W6β2 MHC class-1 epitope. Int. }. Cancer 58: 123-128.
403. La Rocca, S. A., D. H. Crouch, and D. A. Gillespie. 1994. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene. 9: 3499-3508.
404. Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. A. Weinberg. 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. biol. 6: 1917-1925.
405. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science. 222:771-778.
406. Larminat, F., E. J. Beecham, C. J. J. Link, A. May, and V. A. Bohr. 1995. DNA repair in the endogenous and episomal amplified c-myc oncogene loci in human tumor cells. Oncogene. 10: 1639-1645.
407. Lasorella, A., A. lavarone, and M. A. Israel. 1996. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol. Cell. biol. 16: 2570-2578.
408. Lavenu, A., S. Pistai, S. Pournin, C. Babinet, and D. Morello. 1995. Both coding exons of the c-myc gene contribute to its posttranscriptional regulation in the quiescent liver and regenerating liver and after protein synthesis inhibition. Mol. Cell biol. 15: 4410-4419.
409. Le Jossic, C., G. P. Ilyin, P. Loyer, D. Glaise, S. Cariou, and C. Guguen Guillouzo. 1994. Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture. Cancer Res. 54: 6065-6068.
410. Lecourtois, M. and F. Schweisguth. 1995. The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. Gems. Dev. 9: 2598-2608.
411. Lee, H., M. Arsuta, M. Wu, M. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.J. Exp. Med. 181: 1169-1177.
412. Lee, H., M. Wu, F. A. La Rosa, M. P. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. Curr. Top. Microbiol. Immunal. 194: 247-255.
413. Lee, J. E., S. M. Hollenberg, L. Snider, D. L. Turner, N. Lipnick, and H. Weintraub. 1995. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268: 836-844.
414. Lee, L. A., L. M. Resar, and C. V. Dang. 1995. Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts. J. Clin. Invest. 95: 900-904.
415. Lefrancois Martinez, A. M., A. Martinez, B. Antoine, M. Raymondjean, and A. Kahn. 1995. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J. biol. Chem. 270: 2640-2643.
416. Lemaitre, J. M., S. Bocquet, R. Buckle, and M. Mechali. 1995. Selective and rapid nuclear translocation of a c-Myc-containing complex after fertilization of Xenopus laevis eggs. Mol. Cell BioL 15: 5054-5062.
417. Lemaitre, J. M., S. Bocquet, N. Thierry, R. Buckle, and M. Mechali. 1994. Production of a functional fulllength Xenopus laevis c-Myc protein in insect cells. Gene 150: 325-330.
418. Lenahan, M. K. and H. L. Ozer. 1996. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts. Qncogene 12: 1847-1854.
419. Lens, D., E. Matutes, N. Farahat, R. Morilla, and D. Catovsky. 1994. Differential expression of c-myc protein in B and T lymphocytes. Leukemia 8: 2102-2110.
420. Lerga, A., B. Belandia, M. D. Delgado, M. A. Cuadrado, C. Richard, J. M. Ortiz, J. Martin Ferez, and J. Leon. 1995. Down-regulation of c-Myc and Max genes is associated to inhibition of protein phosphatase 2A in K562 human leukemia cells. Biochem. Biopbys. Res. Commun. 215: 889-895.
421. Leroy Viard, K., M. A. Vinit, N. Lecointe, H. Jouault, U. Hibner, P. H. Romeo, and D. Mathieu Mahul. 1995. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion. EMBO J. 14: 2341-2349.
422. Leroy Viard, K., M. A. Vinit, N. Lecointe, D. Mathieu Mahul, and P. H. Romeo. 1994. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood. 84: 3819-3827.
423. Levasseur, M., P. G. Middleton, B. Angus, S. J. Proctor, J. Norden, and M. R. Howard. 1995. c-MYC gene abnormalities in high grade and centroblastic-centrocytic non-Hodgkins lymphoma. Leuk. Lymphoma. 18: 131-136.
424. Lewin, I., J. Jacob Hirsch, Z. C. Zang, V. Kupershtein, Z. Szallasi, J. Rivera, and E. Razin. 1996. Aggregation of the Fc epsilon RI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding-activity: the dependence on protein kinase C-/9. J. Biol. Chera. 271: 1514-1519.
425. Lewin, I., H. Nechushtan, Q. Ke, and E. Razin. 1993. Regulation of AP-1 expression and activity in antigenstimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 82: 3745-3751.
426. Leygue, E., R. Gol Winkler, A. Compel, C. Louis Sylvestre, L. Soquet, S. Staub, F. Kuttenn, and P. Mauvais Jarvis. 1995. Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture. J. Steroid. Biochem. Mol. Biol. 52: 299-305.
427. Li, H., L. Dong, and J. P. J. Whitlock. 1994. Transcriptional activation function of the mouse Ah receptor nuclear translocator. J. Biol. Cbem. 269: 28098-28105.
428. Li, L., P. Cserjesi, and E. N. Olson. 1995. Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172: 280-292.
429. Li, S., T. Maruo, C. A. Ladines Llave, H. Kondo, and M. Mochizuki. 1994. Stage-limited expression of myc oncoprotein in the human ovary during follicular growth, regression and atresia. Endocr. J. 41: 83-92.
430. Lim, K. and B. D. Hwang. 1995. Follicle-stimulating hormone transiently induces expression of protooncogene c-rnyc in primary Sertoli cell cultures of early pubertal and prepubertal rat. Mol. Cell Endocrînol. Ill: 51-56.
431. Lim, K., J. H. Yoo, K. Y. Kim, G. R. Kweon, S. T. Kwak, and B. D. Hwang. 1994. Testosterone regulation of proto-oncogene c-myc expression in primary Sertoli cell cultures from prepubertal rats. J. Androl. 15: 543 -550.
432. Lin, H., R. Goodman, and A. Shirley Henderson. 1994. Spécifie region of the c-myc promoter is responsive to electric and magnetic fields. J. Cell Biochem. 54: 281-288.
433. Lin, Q., X. Luo, and M. Sawadogo. 1994. Archaic structure of the gene encoding transcription factor USF. J. Biol. Chem. 269 23894-23903.
434. Lindeman, G. J., A. W. Harris, M. L. Bath, R. N. Eisenman, and J. M. Adams. 1995. Overexpressed max is not oncogenic and attenuates myc-induced lynwhoproliferation and lymphomagenesis in transgenic mice. Oncogem. 10: 1013-1017.
435. Lipponen, P., M. Eskelinen, and K. Syrjanen. 1995. Expression of tumour-suppressor gene Rb, apoptosissuppressing protfin Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br.J. Cancer 71: 863-867.
436. Lipponen, P. K. 1995. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. J. Pathol. 175: 203-210.
437. Lister, J., W. C. Forrester, and M. H. Baton. 1995. Inhibition of an erythroid differentiation switch by the helix-loop-helix protein Idl. J, Biol. Chem. 270: 17939-17946.
438. Lo, L., F. Guillemot, A. L. Joyner, and D. J. Anderson. 1994. MASH-1: a marker and a mutation for mammalian neural crest development. Perspect. Dev. Neurobiol. 2: 191-201.
439. Lonn, U., S. Lonn, B. Nilsson, and B. Stenkvist. 1995. Prognostic value of erb-B2 and myc amplification in breast cancer imprints. Cancer 75: 2681-2687.
440. Lopez, J. M., M. K. Benne«, H. B. Sanchez, J. M. Rosenfeld, and T. E. Osborne. 1996. Sterol regulation of acttyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. U. S. A. 93: 1049-1053.
441. Lotem, J. and L. Sachs. 1995. A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity. Proc. Natl. Acad. Sci. U. S. A. 92: 9672-9676.
442. Lovée, H., A. Grzeschiczek, M. B. Kowalski, and T. Moroy. 1994. Cyclin Dl/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13: 3487-3495.
443. Lovec, H., A. Sewing, F. C. Lucibello, R. Muller, and T. Moroy. 1994. Oncogenic activity of cyclin Dl revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogem. 9: 323-326.
444. Ludolph, D. C., A. W. Neff, A. L. Mescher, G. M. Malacinski, M. A. Parker, and R. C. Smith. 1994. Overexpression of XMyoD or XMyfS in Xenopus embryos induces the formation of enlarged myotomes through recruitment of cells of nonsomitic lineage. Dev. Biol. 166: 18-33.
445. Luo, X. and M. Sawadogo. 1996. Functional domains of the transcription factor USF2:atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol. Cell. Biol. 16: 1367-1375.
446. Luo, X. and M. Sawadogo. 1996. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc. NatJ. Acad. Sci. U.S.A. 93: 1308-1313.
447. Luo, Y. and M. O. Krause. 1994. Changes in promoter utilization in human and mouse c-myc genes upon transformation induction in temperature-sensitive cell lines. J. Cell Physiol. 160: 303-315.
448. Ma, Q., L. Dong, and J. P. J. Whitlock. 1995. Transcriptional activation by the mouse Ah receptor. Interplay between multiple stimulatory and inhibitory functions. J. Biol. Chem. 270: 12697-12703.
449. Macchi, P., L. Notarangelo, S. Giliani, D. Strina, M. Repetto, M. G. Sacco, P. Vezzoni, and A. Villa. 1995. The genomic organization of the human transcription factor 3 (TFE3) gene. Genomics. 28: 491-494.
450. MacLean Hunter, S., T. P. Makela, A. Grzeschiczek, K. Alitalo, and T. Moroy. 1994. Expression of a rlf/L-myc minigene inhibits differentiation of embryonic stem cells and embroid body formation. Oncogen. 9: 3509-3517.
451. Madisen, L. and M. Groudine. 1994. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes. Dev. 8: 2212-2226.
452. Mai, S. 1994. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. Gene 148: 253-260.
453. Mai, S., J. Hanley Hyde, A. Coleman, D. Siwarski, and K. Huppi. 1995. Amplified extrachromosomal elements containing c-Myc and Pvt 1 in a mouse plasmacytoma. Genome. 38: 780-785.
454. Mai, S., J. Hanley Hyde, and M. Fluti. 1996. c-Myc overexpression associated DHFR gène amplification in hamster, rat, mouse and human cell lines. Qncogene. 12: 277-288.
455. Mai, S. and I. L. Martensson. 1995. The c-myc protein represses the A 5 and TdT initiators. Nucleic Acids Res. 23: 1-9.
456. Majello, B., P. De Luca, G. Suske, and L. Lania. 1995. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Spl-like proteins. Qncogene. 10: 1841-1848.
457. Makela, T. P., E. Hellsten, J. Vesa, H. Hirvonen, A. Palotie, L. Peltonen, and K. Alitalo. 1995. The rearranged L-myc fusion gene (RLF) encodes a Zn-15 related zinc finger protein. Qncogene. 11: 2699-2704.
458. Makino, R., K. Akiyama, J. Yasuda, S. Mashiyama, S. Honda, T. Sekiya, and K. Hayashi. 1994. Cloning and characterization of a c-myc intron binding protein (MIBP1). Nucleic Acids Res. 22: 5679-5685.
459. Malde, P. and M. K. Collins. 1994. Disregulation of Myc expression in murine bone marrow cells results in an inability to proliferate in sub-optimal growth factor and an increased sensitivity to DNA damage. Int. Immunol. 6: 1169-1176.
460. Mallo, M., M. Gendron Maguire, M. L. Harbison, and T. Gridley. 1995. Protein characterization and targeted disruption of Grg, a mouse gene related to the groucho transcript of the Drosophila Enhancer of split complex. Deti. Dyn. 204: 338-347.
461. Malynn, B. A., J. Demengeot, V. Stewart, J. Charron, and F. W. Alt. 1995. Generation of normal lymphocytes derived from N-myc-deficient embryonic stem cells. Int. Immunol. 7: 1637-1647.
462. Manohar, C. F., H. R. Salwen, G. M. Brodeur, and S. L. Cohn. 1995. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes. Chromosomes. Cancer 14: 196-203.
463. Marhin, W. W., Y. J. Hei, S. Chen, Z. Jiang, B. L. Gallic, R. A. Phillips, and L. Z. Penn. 1996. Loss of Rb and Myc activation co-operate to suppress cyclin Dl and contribute to transformation. Qncogene. 12: 43-52.
464. Marin, M. C., B. Hsu, L. C. Stephens, S. Btisbay, and T. J. McDonnell. 1995. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp. Cell Res. 217: 240-247.
465. Marsh, A. G. and C. W. Walker. 1995. Effect of estradiol and progesterone on c-myc expression in the sea star testis and the seasonal regulation of spermatogenesis. Mol. Reprod. Dev. 40: 62-68.
466. Martel, C., D. Lallemand, and C. Cremisi. 1995. Specific c-myc and max regulation in epithelial cells. Oncogens. 10: 2195-2205.
467. Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and M. Caruso. 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene. 9: 3579-3590.
468. Martin, C., A. Prescott, S. Mackay, J. Battle, and E. Vrijlandt. 1991. Control of anthocyanin biosynthesis in flowers of Antirrhinum majus. Plant. J. 1: 37-49.
469. Massari, M. E., P. A. Jennings, and C. Murre. 1996. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomjces cerevisiae and mammalian cells. Mol. Cell Rial. 16: 121-129.
470. Matsunaga, T., H. Shirasawa, M. Tanabe, . Ohnuma, K. Kawamura, T. Etoh, H. Takahashi, and B. Simizu. 1994. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gène amplification in human neuroblastomas. Int. J. Cancer 58: 793-798.
471. Matsunaga, T., H. Takahashi, N. Ohnuma, . Tanabe, H. Yoshida, H. Enomoto, H. Horie, H. Shirasawa, and B. Simizu. 1993. Paratesticular neuroblastoma with N-myc activation. J. Pediatr. Surg. 28: 1612-1614.
472. Mautner, J., S. Joos, T. Werner, D. Eick, G. W. Bornkamm, and A. Polack. 1995. Identification of two enhancer elements downstream of the human c-myc gene. Nucleic Acids Res. 23: 72-80.
473. McKenna, W. G., E. J. Bernhard, D. A. Markiewicz, M. S. Rudoltz, A. Maity, and R. J. Muschel. 1996. Regulation of radiation-induced apoptosis in oncogenetransfected fibroblasts: influence of H-ras on the G2 delay. Oncogene. 12: 237-245.
474. McKenney, D. W., H. Onodera, L. German, T. Mimura, and D. M. Rothstein. 1995. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J. biol. Chem. 270: 24949-24954.
475. McKenzie, E. A., N. A. Kent, S. J. Dowell, . Moreno, L. E. Bird, and J. Mellor. 1993. The centromere and promoter factor, l, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4. Mol. Gen. Genet. 240: 374-386.
476. Megeney, L. A., B. Kablar, K. Garrett, . E. Anderson, and M. A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes. Dev. 10: 1173-1183.
477. Meier, J. L. and S. E. Straus. 1995. Interactions between varicella-zoster virus IE62 and cellular transcription factor USF in the coordinate activation of genes 28 and 29. Neurology. 45: S30-S32.
478. Meinhardt, G. and R. Hass. 1995. Differential xpression of c-myc, max and mxil in human myeloid leukemia cells during retrodifferentiation and cell death. Lenk. Res. 19: 699-705.
479. Meluh, P. B. and D. Koshland. 1995. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol. biol. Cell 6: 793-807.
480. Mermod, N., T. J. Williams, and R. Tjian. 1988. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 332: 557-561.
481. Metz, T., A. W. Harris, and J. M. Adams. 1995. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82: 29-36.
482. Meyer, K. B., M. Skogberg, C. Margenfeld, J. Ireland, and S. Pettersson. 1995. Repression of the immunoglobulin heavy chain 3' enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental cortrol of enhancer function. Ear. J. Immunol. 25: 1770-1777.
483. Michelotti, E. F., T. Tomonaga, H. Krutzsch, and D. Levens. 1995. Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene. J. biol. Chem. 270: 9494-9499.
484. Michelson, A. M. 1996. A new turn (or two) for Twist. Science 272: 1449-1450.
485. Miller, B. A., J. Floros, J. Y. Cheung, D. M. Wojchowski, L. Bell, C. G. Begley, N. J. Elwood, J. Kreider, and C. Christian. 1994. Steel factor affects SCL expression during normal erythroid differentiation. Blood. 84: 2971-2976.
486. Miltenberger, R. J., K. A. Sukow, and P. J. Farnham. 1995. An E-box-mediated increase in cad transcription at the Gi/S-phase boundary is suppressed by inhibitory c-Myc mutants. Vol. Cell Biol. 15: 2527-2535.
487. Mironov, N. M., A. M. Aguelon, G. I. Potapova, O. V. Gorbunov, A. A. Klimenkov, and H. Yamasaki. 1994. L-myc allele polymorphism and prognosis for métastases in Russian gastric cancer patients. Eur. J. Cancer 30A: 1732.
488. Miyamoto, A., X. Cui, L. Naumovski, and M. L. Cleaty. 1996. Helix-loop-helix proteins Lyll and E2a form heterodimenc complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol. Cell. Biol. 16:2394-2401.
489. Miyazaki, T., Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Permuttet, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation. Ce/,'81: 223-231.
490. Mizuguchi, J., C. H. Hu, Z. Cao, K. R. Loeb, D. W. Chung, and E. W. Davie. 1995. Characterization of the 5 -flanking region of the gene for the 7 chain of human fibrinogen. J. biol. Chem. 270: 28350-28356.
491. Mizushima, Y., T. Kashii, and M. Kobayashi. 1995. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides. Anticancer. Res. 15: 37-43.
492. Mizutani, Y., M. Fukumoto, B. Bonavida, and O. Yoshida. 1994. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide. Cancer 74: 2546-2554.
493. Mol, P. C., R. H. Wang, D. W. Batey, L. A. Lee, C. V. Dang, and S. L. Berger. 1995. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin a gene? Mol. Cell biol. 15: 6999-7009.
494. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell S3: 1125-1136.
495. Monk, B. J., J. A. Chapman, G. A. Johnson, B. K. Brightman, S. P. Wilczynski, M. J. Schell, and H. Fan. 1994. Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer. Am. J. Obstet. Cynecol. 171: 1193-1198.
496. Morgenbesser, S. D., N. Schreiber Agus, M. Bidder, K. A. Mahon, P. A. Overbeek, J. Homer, and R. A. DePinho. 1995. Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBÜ J. 14: 743-756.
497. Muller Wieland, D., P. Lochow, N. Banskota, and W. Krone. 1995. Increase of protooncogene c-myc mRNA levels by low density lipoprotein in vascular smooth muscle cells. Biochem. Mol. Biol. Int. 35: 1169-1173.
498. Müller, J. R., S. Janz, J. J. Goedert, M. Potter, and C. S. Rabkin. 1995. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virusinfected homosexual men. Prof. Na/L Acad. Sci. U.S.A. 92: 6577-6581.
499. Muller, J. R., S. Janz, and M. Potter. 1995. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations. Cancer Res. 55: 5012-5018.
500. Muller, J. R., S. Janz, and M. Potter. 1995. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas. Curr. Top. Microbiol. Immunol. 194: 425-429.
501. Müller, J. R., G. M. Jones, M. Potter, and S. Janz. 1996. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction. Cancer Res. 56: 419-423.
502. Muller, J. R., M. Potter, and S. Janz. 1994. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells. Proc. NatJ. Acad. Sci. U. S. A. 91: 12066-12070.
503. Mullick, A., N. Groulx, D. Trasler, and P. Gros. 1995. Nhlhl, a basic helix-loop-helix transcription factor, is very tightly linked to the mouse looptail (Lp) mutation. Mamm, Genome. 6: 700-704.
504. Munsterberg, A. E., J. Kitajewski, D. A. Bumcrot, A. P. McMahon, and A. B. Lassar. 1995. Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes. Den. 9: 2911 -2922.
505. Murrell, A. M., E. O. Bockamp, B. Gottgens, Y. S. Chan, M. A. Cross, C. M. Heyworth, and A. R. Green. 1995. Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. Oncogene. 11: 131 -139.
506. Musaro, A., M. G. Cusella De Angelis, A. Germani, C. Ciccarelli, M. Molinaro, and B. M. Zani. 1995. Enhanced expression of myogenic regulatory genes in aging skeletal muscle. Exp. Celt Res. 221: 241-248.
507. Muscat, G. E., S. Rea, and M. Downes. 1995. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis. Nucleic Acids Res. 23: 1311-1318.
508. Naidu, P. S., D. C. Ludolph, R. Q. To, T. J. Hinterberger, and S. F. Konieczny. 1995. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell biol. 15: 2707-2718.
509. Nakai, J. S. and N. J. Bunce. 1995. Characterization of the Ah receptor from human placental tissue. J. Biocbem. Toxicol. 10: 151-159.
510. Namciu, S., G. E. Lyons, B. K. Micales, H. C. Heyman, C. Colmenares, and E. Stavnezer. 1995. Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro. Dev. Djn. 204: 291-300.
511. Navankasattusas, S., M. Sawadogo, M. van Bilsen, C. V. Dang, and K. R. Chien. 1994. The basic helix-loop-helix protein upstream stimulating factor regulates the cardiac ventricular myosin light-chain 2 gene via independent cis regulatory elements. Mol. Cell biol. 14: 7331-7339.
512. Naya, F. J., C. M. Stellrecht, and M. J. Tsai. 1995. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes. Dev. 9: 1009-1019.
513. Naz, R. K., G. Kumar, and B. S. Minhas. 1994. Expression and role of c-myc protooncogene in murine preimplantation embryonic development. J. Assist. Reprod. Genet. 11: 208-216.
514. Neben, D. W., A. Puga, and V. Vasiliou. 1993. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685: 624-640.
515. Neiman, P. E., J. Summers, S. J. Thomas, S. Xuereb, and G. Loting. 1994. Genetic instability and apoptotic cell death during neoplastic progression of v-mycinitiated B-cell lymphomas in the bursa of Fabricius. Cold. Spring. Hart. Symp. Quant. Biol. 59: 509-515.
516. Neri, A., N. S. Fracchiolla, E. Roscetti, S. Garatti, D. Trecca, A. Boletini, L. Perletti, L. Baldini, A. T. Maiolo, and E. Berti. 1995. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood. 86: 3160-3172.
517. Nervi, C., L. Benedetti, A. Minasi, M. Molinaro, and S. Adamo. 1995. Arginine- vasopressin induces differentiation of skeletal myogenic cells and up-regulation of myogenin and Myf-5. Cell Growth. Differ. 6: 81-89.
518. Neuman, K., H. O. Nornes, and T. Neuman. 1995. Helix-loop-helix transcription factors regulate Id2 gene promoter activity. FEES Lett. 374: 279-283.
519. Nguyen, H. Q., M. Selvakumaran, D. A. Liebermann, and B. Hoffman. 1995. Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. Oncogem. 11: 2439-2444.
520. Nieborowska Skorska, M., M. Z. Ratajczak, . Calabretta, and T. Skorski. 1994. The role of c-Myc protooncogene in chronic myelogenous leukemia. Folia. Histochem. Cytobiol. 32: 231 -234.
521. 2 gene of Saccharomyces cerevisiae. A positive regulator of phospholipid biosynthesis./ Biol. Chem. 269: 7402-7411.
522. 2 gene of Saccharomyces cerevisiae encodes a helix-loop-helix protein that is required for activation of phospholipid synthesis. Nucleic. Acids. Res. 20: 3253.
523. Niwa, O., K. Kamiya, C. Furihata, Y. Nitta, Z. Wang, Y. J. Fan, Y. Ninomiya, N. Kotomura, M. Numoto, and R. Kominami. 1995. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas. Cancer Res. 55: 5670-5676.
524. Noms, M. D., M. Haber, J. Gilbert, M. Kavallaris, G. M. Marshall, and B. W. Stewart. 1994. N-myc gène amplification in neuroblastoma determined by the polymerase chain reaction. Prog. Clin. Biol. Res. 385: 27-33.
525. Nourse, J., J. D. Mellentin, N. Galili, J. Wilkinson, E. Stanbridge, S. D. Smith, and M. L. Cleary. 1990. Chromosomal translocation t(l;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60: 535-545.
526. Numoto, M., K. Yokoro, K. Yanagihara, K. Kamiya, and O. Niwa. 199.c>. Over-expressed ZF5 gene product, a c-myc-binding protein related to GL1-Krüppel protein, has a grouth-suppressive activity in mouse cell lines. ]pn. J. Cancer Res. 86: 277-283.
527. O'Connell, K. F. and R. E. Baker. 1992. Possible cross-regulation of phosphate and sulfate metabolism in Saccharomyces cerevisiae. Genetics 132: 63-73.
528. O'Connell, T. D. and R. U. Simpson. 1995. 1,25- Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart. Biochem. Biophys. Res. Commun. 213: 59-S5.
529. Ohsako, S., J. Hyer, G. Panganiban, I. Oliver, and M. Gaudy. 1994. Hairy function as a DNA-binding helix-loop-helix repressor of Drosophila sensory organ formation. Genes. Den. 8: 2743-2755.
530. Oison, E. N., H-H. Arnold, P. W. J. Rigby, and B. J. Wold. 1996. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85: 1-4.
531. Olson, E. N., M. Perry, and R. A. Schulz. 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. biol. 172: 2-14.
532. Onoda, N., K. Maeda, Y. S. Chung, Y. Yano, I. Matsui Yuasa, S. Otani, and M. Sowa. 1996. Overexpression ot c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach. J. Am. Coll. Surg. 182: 55-59.
533. Orr, M. S., F. A. Fornari, J. K. Randolph, and . A. Gewitz. 1995. Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26. Riochim. Biopbys. Acta 1262: 139-145.
534. Oswald, F., H. Lovée, T. Moroy, and M. Lipp. 1994. E2F-dependent regulation of human MYC:transactivation by cychns Dl and A overrides tumour suppressor proteil functions. Oncogene. 9: 2029-2036.
535. Outram, S. V. and M. J. Owen. 1994. The elix-loop-helh containing transcription factor USF activates the prorioter of the CD2 gene. J. Kot. Chem. 269: 26525-26530.
536. 2-vitamm D-4 induction of homologous receptor and c-myc in nontransformed and transformed C3H/10T1/2 cell clones. Int. J. Biochem. 26: 367-374.
537. Packham, G., C Bello Fernandez, and J. L. Cleveland. 1994. Position and orientation ndependent transactivation by c-Myc. Cell Mol. Biol. Res. 40: 699-706.
538. Packham, G. and J. L. Cleveland. 1995. The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr. Top. Microhiol. Immunol. 194: 283-290.
539. Packham, G. and J. L. Cleveland. 1995. c-Myc and apoptosis. Biothim. Kiophys. Acta 1242: 11 -28.
540. Pagliuca, A., P. C. Bartoli, S. Saccone, G. Delia Valle, and L. Lania. 1995. Molecular cloning of ID4, a novel dominant negative helix-loop-helix human gene on chromosome 6p21.3-p22. Genomics. 27: 200-203.
541. Pai, J. T., M. S. Brown, and J. L. Goldstein. 1996. Purification and cDNA cloning of a second apoptosisrelated cysteine protease that cleaves and activates sterol regulatory element binding proteins. Prof. NatJ. Acad. Sci. U. S. A. 93: 5437-5442.
542. Pallavicini, M. G., T. George, P. S. DeTeresa, R. Amendola, and J. W. Gray. 1994. Intracellular dynamics of c-myc mRNA traffic in single cells in situ. J. Cell PhysioJ. 158: 223-230.
543. Pandey, S. and E. Wang. 1995. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell Biofhem. 58: 135-150.
544. Panno, J. P. and B. A. McKeown. 1995. Cloning and expression of a myc family member from the pituitary gland of the Rainbow trout, Oncorhyncbus my kiss. Eiochim. Biophys. Acta 1264: 7-11.
545. Papas, T. S. and J. A. Lautenberger. 1985. Sequence curiosity in v-myc oncogene. Nature. 318: 237.
546. Paroush, Z., R. L. J. Finley, T. Kidd, . M. Wainwright, P. W. Ingham, R. Brent, and D. Ish Horowicz. 1994. Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell 79: 805-815.
547. Parr, E. J., A. W. Gibson, and K. A. Sharkey. 1994. c-Myc antigens in the mammalian enteric nervous system. Neuroscience. 58: 807-816.
548. Pasqualini, J. R., T. A. Chen, C. Maloche, G. Chetrite, E. Valentin, and V. Allfrey. 1995. Transcriptional activation of the c-myc oncogene in the T-47D mammary cancer cells by conditioned media from embryonic mouse fibroblasts (BALB/C-3T3). Effect of the antiestrogen ICI 164,384. Anticancer. Res. 15: 671-674.
549. Pastorek, J., S. Pastorekova, I. Callebaut, J. P. Mornon, V. Zelnik, R. Opavsky, M. Zat'ovicova, S. Liao, D. Porteteile, E. J. Stanbridge et al. 1994. Cloning and characterization of MN, a human tumorassociated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Onco&ene. 9: 2877-2888.
550. Patapoutian, A., J. K. Yoon, J. H. Miner, S. Wang, K. Stark, and B. Wold. 1995. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development. 121: 3347-3358.
551. Paterson, J. M., C. F. Morrison, S. C. Mendelson, J. McAllister, and J. P. Quinn. 1995. An upstream stimulatory factor (USF) binding motif is critical for rat preprotachykinin-A promoter activity in PC12 cells. Biochem. J. 310:401-406.
552. Patterson, G. I., L. J. Harris, V. Walbot, and V. L. Chandler. 1991. Genetic analysis of B-Peru, a regulatory gene in maize. Genetics 127: 205-220.
553. Patterson, G. I., K. M. Kubo, T. Shroyer, and V. L. Chandler. 1995. Sequences required for paramutation of the maize b gene map to a region containing the promoter and upstream sequences. Genetics 140: 1389-1406.
554. Patterson, G. I., C. J. Thorpe, and V. L. Chandler. 1993. Paramutation, an allelic interaction, is associated with a stable and heritable reduction of transcription of the maize b regulatory gene. Genetics 135: 881-894.
555. Pechoux, C., Y. Chardonnet, M. C. Chignol, and P. Noel. 1994. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes. Histol. Histopathol. 9: 35-44.
556. Peers, B., J. Leonard, S. Sharma, G. Teitelman, and M. R. Montminy. 1994. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol. Endocrinol. 8: 1798-1806.
557. Peleg, Y. and R. L. Metzenberg. 1994. Analysis of the DNA-binding and dimerization activities of Neurospora crassa transcription factor NUC-1. Mol. Cell biol. 14: 7816-7826.
558. Peltenburg, L. T. and P. I. Schrier. 1994. ranscriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements. Immunogenetics. 40: 54-61.
559. Pena, A., S. Wu, N. J. Hickok, D. R. Soprano, and K. J. Soprano. 1995. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex. J. Cell Physiol. 162: 234-245.
560. Perdew, G. H., B. Abbott, and L. H. Stanker. 1995. Production and characterization of monoclonal antibodies directed against the Ah receptor. Hybridotna. 14: 279-283.
561. Peverali, F. A., D. Orioli, L. Tonon, P. Ciana, G. Bunone, M. Negri, and G. Delia Valle. 1996. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene. 12: 457-462.
562. Peverali, F. A., T. Ramqvist, R. Saffrich, . Pepperkok, M. V. Barone, and L. Philipson. 1994. Regulation of Gl progression by E2A and Id helix-loop-helix proteins. EMBO J. 13: 4291-4301.
563. Peyton, M., C. M. Stellrecht, F. J. Naya, . P. Huang, P. J. Samora, and M. J. Tsai. 1996. BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes. Mol. Cell biol. 16: 626-633.
564. Pica, F., O. Franzese, C. D'Onofrio, L. Paganini, . Favalli, E. Bonmassar, and E. Garaci. 1995. Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. Adv. Prostaglandin. Tbromboxane. l-4eukot. Res. 23: 457-459.
565. Pietilainen, T., P. Lipponen, S. Aaltomaa, . Eskelinen, V. M. Kosma, and K. Syrjanen. 1995. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer. Res. 15: 959-964.
566. Plet, A., D. Eick, and J. M. Blanchard. 1995. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns. Oncogene. 10: 319-328.
567. Pollenz, R. S., C. A. Sattler, and A. Poland. 1994. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa Iclc7 cells by immunofluorescence microscopy. Mol. Pharmacol. 45: 428-438.
568. Polly, P. and R. C. Nicholson. 1994. High levels of c-myc gene expression precede point mutational activation of Ki-ras in mouse lung cancer. Cancer Lett. 76: 87-92.
569. Porteus, M. H., A. Bulfone, J. K. Liu, L. Puelles, L. C. Lo, and J. L. Rubenstein. 1994. DLX-2, MASH-1, and MAP-2 expression and bromodeoxyuridine incorporation define molecularly distinct cell populations in the embryonic mouse forebrain. J. Neurosci. 14: 6370-6383.
570. Preisler, H. D., A. Raza, R. Larson, J. Goldberg, G. Tricot, G. Browman, and J. Bennett. 1994. The relationship of the in vivo cell cycle characteristics and treatment outcome in acute myelogenous leukemia to the expression of the FMS and MYC proto-oncogenes. Lenk. Lymphoma. 14: 273-278.
571. Preiss, A., D. A. Hartley, and S. Artavanis Tsakonas. 1988. The molecular genetics of Enhancer of split, a gene required for embryonic neural development in Drosophila. EMBO. J. 7: 3917-3927.
572. Presnell, S. C., M. T. Thompson, and S. C. Strom. 1995. Investigation of the cooperative effects of transforming growth factor a and c-myc overexpression in rat liver epithelial cells. Mol. Carcinog. 13: 233-244.
573. Probst, M. R., S. Reisz Porszasz, R. V. Agbunag, M. S. Ong, and O. Hankinson. 1993. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44: 511-518.
574. Prokipcak, R. D., D. J. Herrick, and J. Ross. 1994. Purification and properties of a protein that binds to the C-terminal coding region of human c-mycmRN A.J. biol. Ow. 269: 9261-9269.
575. Puck, J. M., C. C. Stewart, and P. S. Henthorn. 1991. A high-frequency RFLP at the human TFE3 locus on the X chromosome. Nucleic Acids Res. 19: 684.
576. Pulford, K., N. Lecointe, K. Leroy Viard, M. Jones, D. Mathieu Manul, and D. Y. Mason. 1995. Expression of TAL-1 proteins in human tissues. Blood. 85: 675-684.
577. Raffeld, M., T. Y-ano, A. T. Hoang, B. Lewis, H. M. Clark, T. Otsuki, and C. V. Dang. 1995. Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences. Curr. Top. Microbml. Immunol. 194: 265-272.
578. Rao, G., L. Alland, P. Guida, N. Schreiber-Agus, K. Chen, L. Chin, J. M. Rochelle, M. F. Seidin, A. I. Skoultchi, and R. A. DePinho. 1996. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression domain of the Myc antagonist Mxil. Oncogens. 12: 1165-1172.
579. Raschella, G., A. Romeo, A. Negroni, S. Pucci, C. Dominici, M. A. Castello, P. Bevilacqua, A. Felsani, and B. Calabretta. 1994. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication tor N-myc-MAX complex formation. Cancer Res. 54: 2251-2255.
580. Rawls, A., J. H. Morris, M. Rudnicki, T. Braun, . H. Arnold, W. H. Klein, and E. N. Olson. 1995. Myogenin's functons do not overlap with those of MyoD or Myf-5 d -iring mouse embryogenesis. Dec. biol. 172: 37-50.
581. Ray, R. B. 1995. Induction of cell death in murine ibroblasts by a c-myc promoter binding protein. Cell Growth. Differ. 6: 1089-1096.
582. Reach, M., L. X. Xu, and C. S. Young. 1991. ranscription from the adenovirus major late promoter uses redundant activating elements. hMBO J. 10: 3439-3446.
583. Reddoch, J. F. and D. M. Miller. 1995. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intcnnolccular triplex formation, Biochemistry 34: 7659-7667.
584. Reisz Porszasz, S, M. R. Probst, B. N. Fukunaga, and O. Hankinson. 1994. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell Rial. 14: 6075-6086.
585. Reisz Porszasz, S., H. Reyes, H. F. DeLuca, J. M. Prahl, and O. Hankinson. 1993. Investigation on the potential role of the Ah receptor nuclear translocator protein in vitamin D receptor action. J. Recept. Res. 13: 1147-1159.
586. Rescan, P. Y., L. Gauvry, G. Paboeuf, and B. Fauconneau. 1994. Identification of a muscle factor related to MyoD in a fish species. Koebim. Biophys. Acta 1218: 202-204.
587. Reynolds, J. E., T. Yang, L. Qian, J. D. Jenkinson, P. Zhou, A. Eastman, and R. W. Craig. 1994. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 54: 6348-6352.
588. Rhee, K., W. Bresnahan, A. Hirai, M. Hirai, and . A. Thompson. 1995. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res. 55: 4188-4195.
589. Rhee, K., T. Ma, and E. A. Thompson. 1994. The macromolecular state of the transcription factor E2F and glucocorticoid regulation of c-myc transcription. J. Biol. Chem. 269: 17035-17042.
590. Rhoer Moja, S., H. Bazin, S. Sauvaigo, C. Chypre, and M. Vindimian. 1994. Solid support quantitation of c-myc PCR products using a cleavable reporter. Nucleic Acids Res. 22: 547-548.
591. Rideout, W. M., P. Eversole Cire, C. H. Spruck, C. M. Hustad, G. A. Coetzee, F. A. Gonzales, and P. A. Jones. 1994. Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation. Mol. Cell Biol. 14: 6143-6152.
592. Riechmann, V. and F. Sablitzky. 1995. Mutually exclusive expression of two dominant-negative helix -loop -helix (dnHLH) genes, Id4 and Id3, in the developing brain of the mouse suggests distinct regulatory roles of these dnHLH proteins during cellular proliferation and differentiation of the nervous system. Cell. Growth. Differ. 6: 837-843.
593. Righi, M., O. Letari, P. Sacerdote, F. Marangoni, A. Miozzo, and S. Nicosia. 1995. myc-immortalized microglial cells express a functional platelet-activating factor receptor. J. Neurochem. 64: 121 -129.
594. Rochefort, H. 1995. Oestrogen- and anti-oestrogenregulated genes in human breast cancer. Ciba. Found. Sjmp. 191: 254-265.
595. Rohwedel, J., V. Maltsev, E. Bober, H. H. Arnold, J. Hescheler, and A. M. Wobus. 1994. Muscle cell differentiation of embryonic stem cells reflects myogenesis in ;wo:devclopmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. 164: 87-101.
596. Roman, C., L. Cohn, and K. Calame. 1991. A dominant négative form of transcription activator mTFE3 created by differential splicing. Science 254: 94-97.
597. Romand, R., U. Hirning Folz, and G. Ehret. 1994. N-myc expression in the embryonic cochlea of the mouse. Hear. Res. 72: 53-58.
598. Roncalli, M., G. Bulfamante, G. Viale, . R. Springall, R. Alfano, A. Comi, M. Maggioni, J. M. Polak, and G. Coggi. 1994. C-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta. 15: 399-409.
599. Roncalli, M., G. Viale, L. Grimelius, H. Johansson, E. Wilander, R. M. Alfano, D. Springall, P. M. Battezzati, J. M. Polak, and G. Coggi. 1994. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma. Cancer 74: 134-141.
600. Ronchi, A., K. Petroni, and C. Tonelli. 1995. The reduced expression of endogenous duplications (REED) in the maize R gene family is mediated by DNA methylation. EMBO J. 14: 5318-5328.
601. Rosenthal, S. M. and Z. Q. Cheng. 1995. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Prof. NatJ. Acad. Sci. U. S. A. 92: 10307-10311.
602. Rosolen, A., J. Toretsky, and L. Neckers. 1994. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis. Prog. Clin. Biol. Res. 385: 95-101.
603. Rothberg, P. G. and Y. M. Otto. 1995. A polymorphic variant of human c-Myc: Asnll -> Ser. Mamm. Genome. 6: 209-211.
604. Rothermel, B. A., A. W. Shyjan, J. L. Etheredge, and R. A. Butow. 1995. Transactivation by Rtglp, a basic helix-loop-helix protein that functions in communication between mitochondria and the nucleus in yeast. J. Biol. Chem. 270: 29476-29482.
605. Roussel, M. F., R. A. Ashmun, C. J. Sherr, . E. Eisenman, and D. E. Ayer. 1996. Inhibition of cell proliferation by the Madl transcriptional repressor. Mol. Cell. Biol. 16: 2796-2801.
606. Roy, B., J. Beamon, E. Balint, and D. Reisman. 1994. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell Biol. 14: 7805-7815.
607. Ruiz Ruiz, M. C., F. J. Oliver, M. Izquierdo, and A. Lopez Rivas. 1995. Activation-induced apoptosis in Jurkat cells through a myc-independent mechanism. Mol. Immunol. 32: 947-955.
608. Rushforth, A. M. and P. Anderson. 1996. Splicing removes the Caenorhabditis elegans transposon Tel from most mutant pre-mRNAs. Mol. Cell Biol. 16: 422-429.
609. Safe, S. and V. Krishnan. 1995. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. Suppl. 17: 99-115.
610. Sagara, M., F. Sugiyama, H. Horiguchi, H. Kamma, T. Ogata, K. Yagami, K. Murakami, and A. Fukamizu. 1995. Activation of the nuclear oncogenes N-myc and c-jun in carcinoid tumors of transgenic mice carrying the human adenovirus type 12 El region gene. DNA Cell biol. 14: 95-101.
611. Sakagami, T., K. Sakurada, Y. Sakai, T. Watanabe, S. Nakanishi, and R. Kageyama. 1994. Structure and chromosomal locus of the mouse gene encoding a cerebellar Purkinje cell-specific helix-loop-helix factor Hes-3. Biochem. Biophys. Res. Commun. 203: 594-601.
612. Sakamuro, D., V. Eviner, K. J. Elliott, L. Showe, . White, and G. C. Prendergast. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 11: 2411-2418.
613. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by sterol regulatory element-binding protein and Spl in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270: 1161-1169.
614. Sandgren, E. P., J. A. Schroeder, T. H. Qui, . D. Palmiter, R. L. Brinster, and D. C. Lee. 1995. Inhibition of mammary gland involution is associated with transforming growth factor a but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 55: 3915-3927.
615. Saranath, D., R. G. Panchal, M. G. Deo, V. Sanghvi, and A. R. Mehta. 1994. Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India. Indian J. Biochem. Biophys. 31: 177-183.
616. Sarbassov, D. D., R. Stefanova, V. G. Grigoriev, and C. A. Peterson. 1995. Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line. Proc. Natl. Acad. Sci. U. S. A. 92: 10874-10878.
617. Sato, A., M. Bo, T. Maruo, S. Yoshida, and . Mochizuki. 1994. Stage-specific expression of c-myc messenger ribonucleic acid in porcine granulosa cells early in follicular growth. Eur. J. Endocrinol. 131: 319-322.
618. Sato, K., M. Miyahaia, T. Saito, and M. Kobayashi. 1994. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur. J. Cancer MA.: 1113-1117.
619. Sato, R., J. Yang, X. Wang, M. J. Evans, Y. K. Ho, J. L. Goldstein, and M. S. Brown. 1994. Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J. Biol. Chem. 269: 17267-17273.
620. Saunders, D. E., C. S. Zajac, and N. L. Wappler. 1995. Alcohol inhibits neurite extension and increases N-myc and c-myc proteins. Alcohol. 12: 475-483.
621. Sauter, G., P. Carroll, H. Moch, A. Kallioniemi, R. Kerschmann, P. Narayan, M. J. Mihatsch, and F. M. Waldman. 1995. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am.J. Pathol. 146: 1131-1139.
622. Schaeffer, B. K., P. G. Terhune, and D. S. Longnecker. 1994. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations. Am.J. Pathol. 145: 696-701.
623. Schmidt, M. L., H. R. Salwen, C. F. Manohar, N. Ikegaki, and S. L. Cohn. 1994. The biological effects of antisense N-myc expression in human neuroblastoma. Ce'.l Growth. Differ. 5: 171 -178.
624. Schneider, K. R., R. L. Smith, and E. K. O'Shea. 1994. Phosphate-regulated inactivation of the kinase PHO80-PHO85 by the CDK inhibitor PHO81. Science 266: 122-126.
625. 1916a. Schreiber-Agus, N., Stein, D., Chen, K., Goltz, J. S., Stevens, L. and DePinho, R. A. 1997. Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc. NatJ. Acad. Sci. U.S.A. 94: 1235-1240.
626. Schuller, H. J., K. Richter, B. Hoffmann, R. Ebben, and E. Schweizer. 1995. DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesis. FEBS Lett. 370: 149-152.
627. Schuller, H. J., R. Schorr, B. Hoffmann, and E. Schweizer. 1992. Regulatory gene INO4 of yeast phospholipid biosynthesis is positively autoregulated and functions as a transactivator of fatty acid synthase genes FAS1 and FAS2 from Saccharomyces cerevisiae. Nucleic. Acids. Res. 20: 5955-5961.
628. Schwab, M. 1994. Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome Ip. Recent. Results. Cancer Res. 135: 7-16.
629. 2 interacts as an Ino2p/ Ino4p basic helix_loop-helix heteromeric complex with the inositol/choline-responsive element necessary for expression of ohospholipid biosynthetic genes in Saccharomyces cerevisiae. Nucleic Acids Res. 23: 230-237.
630. Schwanz, B., D. Benharroch, I. Prinsloo, E. Cagnano, and S. A. Lamprecht. 1995. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonie epithelium of normal and dimethylhydrazinetreated rats: an immunohistochemical analysis. Anticancer. Res. 15: 211-218.
631. Seckinger, P., M. Milili, C. Schiff, and M. Fougereau. 1994. Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization. Eur. J. Immunol. 24: 716-722.
632. Serra, R., R. W. Pelton, and H. L. Moses. 1994. TGF β-f inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. Development. 120: 2153-2161.
633. Seruca, R., R. F. Suijkerbuijk, F. Gärtner, B. Criado, I. Veiga, D. Olde Weghuis, L. David, S. Castedo, and M. Sobrinho Simoes. 1995. Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet. Cytogenet. 82: 140-145.
634. Sethupathi, P., H. Spieker Polet, H. Polet, P. C. Yam, C. Tunyaplin, and K. L. Knight. 1994. Lymphoid and non-lymphoid tumors in E K-myc transgenic rabbits. Leukemia 8: 2144-2155.
635. Shain, D. H., T. Neuman, and M. X. Zuber. 1995. A novel initiator regulates expression of the nontissuespecific helix-loop-helix gene ME1. Nucleic Acids Res. 23: 1696-1703.
636. Shain, D. H. and M. X. Zuber. 1995. Identification of non-tissue-specific helix-loop-helix genes in Xenopus laevis. Gene 165: 319-320.
637. Sharma, S., J. Leonard, S. Lee, H. D. Chapman, E. H. Leiter, and M. R. Montminy. 1996. Pancreatic islet expression of the homeobox factor STF-1 relies on an E-box motif that binds USF. J. biol. C.hem. 271: 2294-2299.
638. Sheng, Z., H. Otani, M. S. Brown, and J. L. Goldstein. 1995. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Prof. NatJ. Acad. Sci. U. S. A. 92: 935-938.
639. Shi, Y., A. Fard, A. Galeo, H. G. Hutchinson, P. Vermani, G. R. Dodge, D. J. Hall, F. Shaheen, and A. Zalewski. 1994. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation. 90: 944-951.
640. Shimada, H., D. O. Stram, J. Chatten, V. V. Joshi, Y. Hachitanda, G. M. Brodeur, J. N. Lukens, K. K. Matthay, and R. C. Seeger. 1995. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J. Na/l. Canter lust. 87: 1470-1476.
641. Shimamoto, T., K. Ohyashiki, J. H. Ohyashiki, K. Kawakubo, T. Fujimura, H. Iwama, S. Nakazawa, and K. Toyama. 1995. The expression pattern of erythrocyte/megakaryocyterelated transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood. 86: 3173-3180.
642. Shimizu, C., C. Akazawa, S. Nakanishi, and R. Kageyama. 1995. MATH-2, a mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal, is specifically expressed in the nervous system. Ear. J. Biocbem. 229: 239-248.
643. Shimizu, N., H. Nakamura, T. Kadota, K. Kitajima, T. Oda, T. Hirano, and H. Utiyama. 1994. Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells. Cancer Res. 54: 3561-3567.
644. Shivdasani, R. A., E. L. Mayer, and S. H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373: 432-434.
645. Shrivastava, A. and K. Calame. 1995. Association with c-Myc: an alternated mechanism for c-Myc function. Curr. Top. Microbiol. Immunol. 194: 273-282.
646. Shung, B., J. Miyakoshi, and H. Takebe. 1994. X-ray-induced transcriptional activation of c-myc and XRCC1 genes in ataxia telangiectasia cells. Mutât. Res. 307: 43-51.
647. Siderovski, D. P., S. P. Heximer, and D. R. Forsdyke. 1994. A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell biol. 13: 125-147.
648. Sigvardsson, M., K. Johansson, L. G. Larsson, K. Nilsson, and T. Leanderson. 1994. Ectopic expression of myc or myn down-regulates immunoglobulin transcription. Leukemia 8: 1157-1163.
649. Simile, M. M., R. Pascale, M. R. De Miglio, A. Nufris, L. Daino, M. A. Seddaiu, L. Gaspa, and F. Feo. 1994. Correlation between J'-adenosyl-Lmethionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer L,ett. 79: 9-16.
650. Simm, A., J. P. Halle, and G. Adam. 1994. Proliferative and metabolic capacity of rat embryo fibroblasts immortalized by c-myc depends on cellular age at oncogenic transfection. Eur. J. Cell Biol. 65: 121-131.
651. Simon, H. G., C. Nelson, D. Goff, E. Laufer, B. A. Morgan, and C. Tabin. 1995. Differential expression of myogenic regulatory genes and Msx-1 during dedifferentiation and redifferentiation of regenerating amphibian limbs. Dev. Dyn. 202: 1-12.
652. Singh, I. S., Z. Luo, M. T. Kozlowski, and J. Erlichman. 1994. Association of USF and c-Myc with a helix-loop-helix-consensus motif in the core promoter of the murine type II βregulatory subun.it gene of cyclic adenosine 3',5'-monophosphatedependent protein kinase. Mol. Endocrinol. 8: 1163-1174.
653. Skerjanc, I. S., R. S. Slack, and M. W. McBurney. 1994. Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells. Mol. CW/B/oJ. 14:8451-8459.
654. Skerjanc, I. S., J. Truong, P. Filion, and M. W. McBurney. 1996. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity. J. Rial. Chem. 271: 3555-3561.
655. Skoda, R. C., S. F. Tsai, S. H. Orkin, and P. Leder. 1995. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J. Exp. Med. 181: 1603-1613.
656. Skorski, T., M. Nieborowska Skorska, K. Campbell, R. V. lozzo, G. Zon, Z. Darzynkiewicz, and B. Calabretta. 1995. Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. J. Exp. Med. 182: 1645-1653.
657. Sleight, B. J., S. Soukup, E. T. Ballard, and L. M. Parysek. 1993. S-cells from a highly N-myc-arnplified neuroblastoma are tumorigenic in nude mice. Anticancer. Res. 13: 2031-2036.
658. Slovak, M. L., J. P. Ho, M. J. Pettenati, A. Khan, D. Douer, S. Lal, and S. T. Traweek. 1994. Localization of amplified MYC gene sequences to double minute chromosomes in acute myelogenous leukemia. Genes. Chromosom. Cancer 9: 62-67.
659. Smith, T. H., A. M. Kachinsky, and J. B. Miller. 1994. Somite subdomains, muscle cell origins, and the four muscle regulatory factor proteins. J. Cell Biol. 127: 95-105.
660. Smith-Sorensen, B., E. M. Hijmans, . L. Beijersbergen, and R. Bernards. 1996. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins. J. Biol. Chem. 271: 5513-5518.
661. Sogawa, K., K. Iwabuchi, H. Abe, and Y. Fujii uriyama. 1995. Transcriptional activation domains of the Ah receptor and Ah receptor nuclear translocator. J. Cancer Res. Clin. Oncol. 121: 612-620.
662. Sogawa, K., R. Nakano, A. Kobayashi, Y. Kikuchi, N. Ohe, N. Matsushita, and Y. Fujii Kuriyama. 1995. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc. Natl. Acad. Sci. U. S. A. 92: 1936-1940.
663. Soini, Y., A. Mannermaa, R. Winqvist, D. Kamel, K. Poikonen, H. Kiviniemi, and P. Paakko. 1994. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma. J. Histochem. Cytochem. 42: 795-803.
664. Solomon, D. L., A. Philipp, H. Land, and M. Eilers. 1995. Expression of cyclin Dl mRNA is not upregulated by Myc in rat fibroblasts. Oncogens. 11: 1893-1897.
665. Spaventi, R., E. Kamenjicki, N. Pecina, S. Grazio, J. Pavelic, B. Kusic, D. Cvrtila, Z. Danilovic, S. Spaventi et al. 1994. Immunohistochemical detection of TGF-a, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression. In. Vivo. 8: 183-189.
666. Spicer, D. B., J. Rhee, W. L. Cheung, and A. B. Lassar. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272: 1476-': 480.
667. Srivastava, D., P. Cserjesi, and E. N. Olson. 1995. A subclass of bHLH proteins required for cardiac morphogenesis. Science 270: 1995-1999.
668. Stasiv, Y. Z., T. D. Mashkova, B. K. Chernov, I. V. Sokolova, A. V. Itkes, and L. L. Kisselev. 1994. Cloning of a cDN \encoding a human protein which binds a sequence in the c-myc gene similar to the interferon-stimulated response element. Gene 145: 267-272.
669. Steiner, P., A. Philipp, J. Lukas, D. Godden Kent, M. Pagano, S. Mittnacht, J. Bartek, and M. Eilers. 1995. Identification of a Myc-dependent step during the formation of active; Gl cyclin-cdk complexes. EMBO J. 14: 4814-4826.
670. Steiner, S. M., Y. Hu, and M. R. Steiner. 1995. Regulation of pro'itaglandin H synthase l and 2 in MyoD transfected cells. Exp. Cell Res. 218: 389-393.
671. Steingrimsson, E., K. J. Moore, M. L. Lamoreux, D. A. Ferre, S. K. Burley, D. C. Zimring, L. C. Skow, C. A. Hodgkinson, H. Arnheiter, N. G. Copeland al. 1994. Molecular basis of mouse microphthalmia (ni) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8: 256-263.
672. Steingrimsson, K., M. Sawadogo, D. J. Gilbert, A. S. Zervos, R. Brent, M. A. Blanar, D. E. Fisher, N. G. Copeland, and N. A. Jenkins. 1995. Murine chromosomal location of five bHLH-Zip transcription factor genes. Genomics. 28: 179-183.
673. Stocker, U., A. Schaefer, and H. Marquardt. 1995. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline mtitumor antibiotic aclarubicin. Leukemia1): 146-154.
674. Streicher, R., J. Kotzka, D. Muller-Wieland, G. Siemeister, M. Munck, H. Avci, and W. Krone. 1996. SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulinlike growth factor-1. J. biol. Chem. 271: 7128-7133.
675. Suda, K., H. O. Nornes, and T. Neuman. 1994. Class A basic helix-loop-helix transcription factors in early stages of chick neural tube development: evidence for funcàonal redundancy. Neurosci. Lett. 177: 87-90.
676. Sugimoto, T., F. Tsukamato, M. Fujita, and S. Takai. 1994. Ki-ras and c-myc oncogene expression measured by (amplification polymerase chain reaction. Biochem. Biophys. Res. Commun. 201: 574-580.
677. Sun, X. H. 1994. Constitutive expression of the Idl gene impairs mouse B cell development. Cell 79: 893-900.
678. Svaren, J. and W. Horz. 1995. Interplay between nucleosomes and transcription factors at the yeast PHO5 promoter. Semin. Cell Biol. 6: 177-183.
679. Svaren, J., J. Schmilz, and W. Horz. 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBOJ. 13: 4856-4862.
680. Swanson, H. I. and C. A. Bradfield. 1993. The AH-receptor: genetics, structure and function. Pharmacogenetics. 3: 213-230.
681. Tabib, A. and U. Bachrach. 1994. Activation of the proto-oncogene c-myc and c-fos by c-ras: involvement of polyamines. Biochem. Biophys. Res. Commun. 202: 720-727.
682. Tachibana, M., L. A. Ferez Jurado, A. Nakayama, C. A. Hodgkinson, X. Li, M. Schneider, T. Miki, J. Fex, U. Francke, and H. Arnheiter. 1994. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.l-pl2.3. Hum. Mol. Genet. 3: 553-557.
683. Tajbakhsh, S. and M. E. Buckingham. 1995. Lineage restriction of the myogenic conversion factor myf-5 in the brain. Development. 121: 4077-4083.
684. Takahashi, N., U. Harttig, D. E. Williams, and . S. Bailey. 1996. The model Ah-receptor agonist βnaphthoflavone inhibits aflatoxin Bl-DNA binding in i'ivo in rainbow trout at dietary levels that do not induce CYP1A enzymes. Carcinogenesis 17: 79-87.
685. Takai, T., Y. Nishita, S. M. Iguchi Ariga, and H. Ariga. 1994. Molecular cloning of MSSP-2, a c-myc gene single-strand binding protein: characterization of binding specificity and DNA replication activity. Nucleic Acids Res. 22: 5576-5581.
686. Takebayashi, K., C. Akazawa, S. Nakanishi, and R. Kageyama. 1995. Structure and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-5. Identification of the neural precursor cell-specific promoter element. J. Biol. Chem. 270: 1342-1349.
687. Tamura, M. and M. Noda. 1994. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J. Cell Biol. 126: 773-782.
688. Tanaka, N., M. Ishihara, and T. Taniguchi. 1994. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett. 83: 191-196.
689. Tanaka, T., R. C. Seeger, M. Tanabe, E. Hiyama, H. Shimoda, and N. Ida. 1994. Prognostic prediction in neuroblasromas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification. Cancer Detect. Prev. 18: 283-289.
690. Tanigawa, T., N. Elwood, D. Metcalf, D. Cary, E. DeLuca, N. A. Nicola, and C. G. Begley. 1993. The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Prof. NatJ. Acad. Sci. U. S. A. 90: 7864-7868.
691. Tanji, K., S. Sancho, and A. F. Miranda. 1994. Innervation of MyoD-converted human amniocytes and fibroblasts by fetal rodent spinal cord neurons. Neuromuscul. Disord. 4: 317-324.
692. Tappero, G., G. Natoli, G. Anfossi, F. Rosina, F. Negro, A. Smedile, F. Bonino, A. Angeli, R. H. Purcell, M. Rizzetto et al. 1994. Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus. Hepatology 20: 1109-1114.
693. Tarakhovsky, A., M. Turner, S. Schaal, P. J. Mee, L. P. Duddy, K. Rajewsky, and V. L. Tybulewicz. 1995. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374 467-470.
694. Täte, J. E., G. L. Mutter, C. J. Prasad, R. Berkowitz, H. Goodman, and C. P. Crum. 1994. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gymcol. Oncol. 53: 78-83.
695. Tatsuta, M., H. lishi, M. Baba, A. Nakaizumi, H. Uehara, and H. Taniguchi. 1994. Expression of c-myc mRNA as an aid in histologie differentiation of adenoma from well differentiated adenocarcinoma in the stomach. Cancer 73: 1795-1799.
696. Tavtigian, S. V., S. D. Zabludoff, and B. J. Wold. 1994. Cloning of mid-Gl serum response genes and identification of a subset regulated by conditional myc expression. Mol. biol. Cell 5: 375-388.
697. Tedesco, D., M. Caruso, L. Fischer Fantuzzi, and C. Vesco. 1995. The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69: 6947-6957.
698. Theopold, U., S. Ekengren, and D. Hultmark. 1996. HLH106, a Dmsophila transcription factor with similarity to the vertebrate sterol responsive element binding protein. Proc. NatJ. Acad. Sci. U. S. A. 93: 1195-1199.
699. Thompson, E. B., R. Thulasi, M. F. Saeed, and B. H. Johnson. 1995. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells. -44. N. Y. Acad. Sci. 761: 261-275.
700. Tikhonenko, A. T., D. J. Black, and M. L. Linial. 1995. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype. Oncogene. 11: 1499-1508.
701. Timchenko, N., D. R. Wilson, L. R. Taylot, S. Abdelsayed, M. Wilde, M. Sawadogo, and G. J. Darlington. 1995. Autoregulation of the human C/EBP a gene by stimulation of upstream stimulatory factor binding. Mol. Cell biol. 15: 1192-1202.
702. Tobias, K. E., J. Shor, and C. Kahana. 1995. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene. 11: 1721-1727.
703. Toda, T., T. Tamamoto, S. Shimajiri, A. M. Sadi, Y. Nakashima, and H. Takei. 1995. Expression of PDGF and C-myc in atherosclerotic lesions in cholesterol-fed chicken. Immunohistochemical and in situ hybridization study. -44. N. Y. Acad. Sci. 748: 514-516.
704. Tomonaga, T., H. Hayashi, M. Taira, K. Isono, and I. Kojima. 1994. Signaling pathway other than phosphatidylinositol turnover is responsible for constant expression of c-myc gene in primary cultures of rat hepatocytes. Biochem. Mol. Bief. Int. 33: 429-437.
705. Tonj es, R. R., J. Lohler, J. F. O'Sullivan, G. F. Kay, G. H. Schmidt, W. Dalemans, A. Pavirani, and D. Paul. 1995. Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice. Oncogene. 10: 765-768.
706. Toren, A. and G. Rechavi. 1994. The anti-apoptotic role of infectious agents in lymphoid malignancies characterized by c-myc deregulation. Br. J. Haematol. 87: 675-677.
707. Tournay, O. and R. Benezra. 1996. Transcription of the dominant-negative helix-loop-helix protein Idl is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol. Cell. biol. 16: 2418-2430.
708. Troussard, X., R. Rimokh, F. Valensi, D. Leboeuf, O. Fenneteau, A. M. Guitard, A. M. Manel, F. Schillinger, C. Leglise, A. Brizard et al. 1995. Heterogeneity of t(l;19)(q23;pl3) acute leukaemias. French Haematological Cytology Group. Br. J. Haematol. 89: 516-526.
709. Trudel, M., N. Chrétien, and V. D'Agati. 1994. isappearance of polycystic kidney disease in revertant c-myc transgenic mice. Mamm. Genome. 5: 149-152.
710. Uittenbogaard, M. N., A. P. Armstrong, . Chiaramello, and J. K. Nyborg. 1994. Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J. biol. Chem. 269: 22466-22469.
711. Uittenbogaard, M. N., H. A. Giebler, D. Reisman, and J. K. Nyborg. 1995. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J. biol. Chem. 270: 28503-28506.
712. Umbhauer, M., J. F. Riou, J. C. Smith, and . C. Boucaut. 1994. Control of somitic expression of tenascin in Xenopus embryos by myogenic factors and Brachyury. Dev. Djn. 200: 269-277.
713. Usa, T., T. Tsukazaki, H. Namba, A. Ohtsum, H. Kimura, M. C. Villadolid, S. Nagataki, and S. Yamashita. 1994. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-β! in thyroid carcinoma cell growth. Endocrinology 135: 1378-1384.
714. Vairo, G., P. K. Vadiveloo, A. K. Royston, S. P. Rockman, C. O. Rock, S. Jackowski, and J. A. Hamilton. 1'395. Deregulated c-myc expression overrides IFN7-induced macrophage growth arrest. Oncogene. 10: 1969-1976.
715. Valera, A., A. Pujol, X. Gregori, E. Riu, J. Visa, and F. Bosch. 1995. Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB. J. 9: 1067-1078.
716. van Dam, P. A., 1. B. Vergote, D. G. Löwe, J. V. Watson, P. van Damme, J. C. van der Auwera, and J. H. Shepherd. 1994. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma. J. Clin. Pathol. 47: 914-919.
717. van der Lugt, N. M., J. Domen, E. Verhoeven, K. Linders, H. van der Gulden, J. Allen, and A. Berns. 1995. Ptoviral tagging in E /i-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 14: 2536-2544.
718. Vandromme, M., J. C. Cavadore, A. Bonnieu, . Froeschle, N. Lamb, and A. Fernandez. 1995. Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independently. Proc. Natl. Acad. Sci. U. S. A. 92: 4646-4650.
719. Vastrik, I., A. Kaipainen, T-L. Penttila, A. Lymboussakis, R. Alitalo, M. Parninen, and K. Alitalo. 1995. Expression of the mail gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. CellBiol. 128: 1197-1208.
720. Vastrik, I., T. P. Makela, P. J. Koskinen, and K. Alitalo. 1995. Determination of sequences responsible for the differential regulation of Myc function by 6 Ma:: and Max. Oncogene. 11: 553-560.
721. Vaulont, S. and A. Kahn. 1994. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB. J. 8: 28-35.
722. Veal, E. A. and M. J. Jackson. 1995. Expression of c-fos and c-myc in satellite cell cultures from dystrophic dx and control mouse muscle. Biochem. Soc. Trans. 23: 456S.
723. Veal, E. A. and M. J. Jackson. 1995. Expression of the proto-oncogenes c-fos and c-myc in mdx dystrophic mouse muscle. Biochem. Soc. Trans. 23: 131 S.
724. Veronese, M. L., M. Ohta, J. Finan, P. C. Nowell, and C. M. Croce. 1995. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. Blood. 85: 2132-2138.
725. Vierra, C. A. and C. Nelson. 1995. The Pan basic helix-loop-helix proteins are required for insulin gene expression. Mol. Endocrinol. 9: 64-71.
726. Vierta, C. A., X. Q. Xin, Y. T. Jacobs, J. M. Campbell, L. P. Shen, W. J. Rutter, and C. Nelson. 1994. Purification of E. fo//'-synthesized Pan proteins and development of a Pan-specific monoclonal antibody. Hybridoma. 13: 191-197.
727. Vostrov, A. A., W. W. Quitschke, F. Vidai, A. L. Schwarzman, and D. Goldgaber. 1995. USF binds to the APB a sequence in the promoter of the amyloid β-protein precursor gene. Nucleic Acids Res. 23: 2734-2741.
728. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21wafl/cipl. Genes. Dev. 8: 2817-2830.
729. Waller, C. L. and J. D. McKinney. 1995. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 8: 847-858.
730. Wang, A., N. Yoshimi, T. Tanaka, and H. Mori. 1993. Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett. 75: 73-78.
731. Wang, D. and H. S. Sul. 1995. Upstream stimulatory factors bind to insulin response sequence of the fatty acid synthase promoter. USF1 is regulated. J. BioL Chem. 270: 28716-28722.
732. Wang, E. and S. Pandey. 1995. Down-regulation of statin, a nonproliferation-specific nuclear protein, and up-regulation of c-myc after initiation of programmed cell death in mouse fibroblasts. J. Cell Physiol. 163: 155-163.
733. 2 tension, froc. NatJ. Acad. Sci. U. S. A. 92: 5510-5514.
734. Wang, G. L. and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor I and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268: 21513-21518.
735. Wang, G. L. and G. L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor l. J. Biol. Chem. 270: 1230-1237.
736. Wang, J., K. Helin, P. Jin, and B. Nadal-Ginard. 1996. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth. Differ. 6: 1299-1306.
737. Wang, J., L. Li, S. Li, H. Cui, and G. Shen. 1994. A study of c-myc oncogene expression and amplification in colorectal cancer. Chin. Med. Sci. J. 9: 24-28.
738. Wang, J. Y. and L. R. Johnson. 1994. Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers. Am. J. Physiol. 266:G878-G886.
739. Wang, N. P., J. Marx, M. A. McNutt, J. C. Rutledge, and A. M. Gown. 1995. Expression of myogenic regulatory proteins (myogenin and MyoDl) in small blue round cell tumors of childhood. Am. J. Pathol. 147: 1799-1810.
740. Wang, S., J. V. Bartolome, and S. M. Schanberg. 1996. Neonatal deprivation of maternal touch may suppress ornithine decarboxylase via downregulation of the proto-oncogenes c-myc and max. J. Neurosci. 16: 836-842.
741. Wang, X., J. T. Pai, E. A. Wiedenfeld, J. C. Medina, C. A. Slaughter, J. L. Goldstein, and M. S. Brown. 1995. Purification of an interleukin-1 0 converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J. Biol. Chem. 270: 18044-18050.
742. Wang, X. and S. Safe. 1994. Development of an in vitro model for investigating the formation of the nuclear Ah receptor complex in mouse Hepa Iclc? cells. Arch. Biochem. Biophys. 315: 285-292.
743. Wang, X. H., C. A. Whyzmuzis, S. An, Y. Chen, J. M. Wu, T. A. Schneidau, C. Mallouh, and H. Tazaki. 1994. Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 120-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells. Biochem. Mol. Biol. Int. 34: 47-53.
744. Wang, Y., P. N. Schnegelsberg, J. Dausman, and R. Jaenisch. 1996. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature. 379: 823-825.
745. Wang, Z., D. L. Morris, and T. L. Rothstein. 1995. Constitutive and inducible levels of egr-1 and c-myc early growth response gene expression in self-renewing B-l lymphocytes. Cell Immunol. 162: 309-314.
746. Wassermann, K., P. M. O'Connor, J. Jackman, A. May, and V. A. Bohr. 1994. Transcriptionindependent repair of nitrogen mustard-induced JV-alkylpurines in the c-myc gene in Burkitt's lymphoma CA46 cells. Careinogenesis 15: 1779-1783.
747. Watada, H., Y. Kajimoto, Y. Umayahara, T. Matsuoka, T. Morishima, Y. Yamasaki, R. Kawamori, and T. Kamada. 1995. Ubiquitous, but variable, expression of two alternatively spliced mRNAs encoding mouse homologues of transcription factors E47 and E12. Gene 153: 255-259.
748. Watanabe, S., S. Ishida, K. Koike, and K. Aral. 1995. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor. Mol. biol. Cell 6: 627-636.
749. Watanabe, Y., K. Kawakami, Y. Hirayama, and K. Nagano. 1993. Transcription factors positively and negatively regulating the Na,K-ATPase a\ subunit gene. J. Biochem. Tokyo. 114: 849-855.
750. Watt, F. and P. L. Molloy. 1993. Specific cleavage of transcription factors by the thiol protease, m-calpain. Nucleic Acids Res. 21: 5092-5100.
751. Weinberg, E. S., M. L. Allende, C. S. Kelly, A. Abdelhamid, T. Murakami, P. Andermann, O. G. Doerre, D. J. Grunwald, and B. Riggleman. 1996. Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos. Development. 122: 271-280.
752. West, M. J., N. F. Sullivan, and A. E. Willis. 1995. Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines. Oncogene. 11: 2515-2524.
753. Weston, A., H. M. Ling Cawley, N. E. Caporaso, E. D. Bowman, R. N. Hoover, B. F. Trump, and C. C. Harris. 1994. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15: 583-587.
754. Whitelaw, M. L., J. A. Gustafsson, and L. Poellinger. 1994. Identification of transact!vation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt:inducible versus constitutive modes of regulation. Mol. Cell Biol. 14: 8343-8355.
755. Wiener, F., A. Coleman, B. A. Mock, and M. Potter. 995. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Cancer Res. 55: 1181-1188.
756. Wilhelmsson, A., M. L. Whitelaw, J. A. Gustafsson, and L. Poellinger. 1994. Agonistic and antagonistic effects of a-naphthoflavone on dioxin receptor function. Role of the basic region helix-loop-helix dioxin receptor partner factor Arnt. J. Biol. Chem. 269: 19028-19033.
757. Wilk, R., I. Weizman, and B. Z. Shilo. 1996. rachealess encodes a bHLH-PAS protein that is an inducer of trachéal cell fates in Drosophila. Genes. Dev. 10: 93-102.
758. Wolberger, C. 1994. b/HLH without the zip. Nat. Struct. biol. 1: 413-416. [Published erratum appears in 1994. Nat. Struct. biol. 1:829.]
759. Wolfl, S., B. Wittig, and A. Rich. 1995. Identification of transcriptionally induced Z-DNA segments in the human c-myc gene. Biothim. Biophys. Acta 1264: 294-302.
760. Woloschak, M., J. L. Roberts, and K. Post. 1994. c-myc, c-fos, and c-rnyb gene expression in human pituitary adenomas. J. Clin, tindocrinol. Metab. 79: 253-257.
761. Wong, K. K., J. D. Hatdin, S. Boast, C. L. Cooper, K. T. Merrell, T. G. Doyle, S. P. Goff, and K. L. Calame. 1995 A role for c-Abl in c-myc regulation. Oncogene. 10: 705-711.
762. Wong, K. K., X. Zou, K. T. Merrell, A. J. Patel, K. B. Marcu, S. Chellappan, and K. Calame. 1995. vAbl activates c-myc transcription through the E2F site. Mol. Cell biol. 15: 6535-6544.
763. Wong, M. W., M. Pisegna, M. F. Lu, D. Leibham, and M. Perry. 1994. Activation of Xenopus MyoD transcription by members of the MEF2 protein family. Den. biol. 166: 683-695.
764. Wood, A. C., P. El vin, and J. A. Hickman. 1995. Induction of apoptc sis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br. J. Cancer 71: 937-941.
765. Woodruff, K. A., J. D. Rosenblatt, T. B. Moore, R. H. Medzoyan, D. S. Pai, J. L. Noland, J. M. Yamashiro, and R. K. Wada. 1995. Cell typespecific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer. Oncogene. 10: 1335-1341.
766. Wright, S., X. Lu, and B. M. Peterlin. 1994. Human immunodeficiency virus type 1 tat directs transcription through attenuatior sites within the mouse c-myc gene. J. Mol. Biol. 243: 568-573.
767. Wu Pong, S., T. L. Weiss, and C. A. Hunt. 1994. Antisense c-myc oligonucleotide cellular uptake and activity. Antisense. Res. Den. 4: 155 -163.
768. Wu, H. K., H. H. Heng, X. M. Shi, D. R. Forsdyke, L. C. Tsui, T. W. Mak, M. D. Minden, and D. P. Siderovski. 995. Differential expression of a basic helix-loop-helix phosphoprottin gene, GOS8, in acute leukemia and localization to human chromosome Iq31. leukemia 9: 1291-1298.
769. Wu, J., S. Katzav, and A. Weiss. 1995. A functional T-cell receptor signaling pathway is required for p95vav activity. Mol. Cell biol. 15: 4337-4346.
770. Wu, S., A. Pena, A. Korcz, D. Robert-Soprano, and K. J. Soprano. 1996. Overexpression of Mxil inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene. 12: 621-629.
771. Wulbeck, C., C. Fromental Ratnain, and J. A. ampos Ortega. 1994. The HLH domain of a zebrafish HE12 homologue can partially substitute for functions of the HLH domain of Drosophila DAUGHTERI.ESS. Me A. Dei: 46: 73-85.
772. Wulf, G. M., C. N. Adra, and B. Lim. 1993. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMRO ). 12: 5065-5074.
773. Xiao, G. H., J. A. Pinaire, A. D. Rodrigues, and . A. Plough. 1995. Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes. Drug. Me/ah. Dispos. 23: 642-650.
774. Xu, L., Y. Meng, R. Wallen, and R. A. DePinho. 1995. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype. Qncogene. 11: 1865-1872.
775. Xu, L., D. Rungger, O. Georgiev, K. Seipel, and W. Schaffner. 1994. Different potential of cellular and viral activators of transcription revealed in oocytes and early embryos of Xenopus laevis. RioJ. Chem. Hoppe. Seyler. 375: 105-112.
776. Yang, J., M. S. Brown, Y. K. Ho, and J. L. Goldstein. 1995. Three different rearrangements in a single intron truncate sterol regulatory element binding protein-2 and produce sterol-resistant phenotype in three cell lines. Role of introns in protein evolution. J. RioJ. Chem. 270: 12152-12161.
777. Yasumoto, K., K. Yokoyama, K. Shibata, Y. Tomita, and S. Shibahara. 1994. Microphthalmia-associated transcription factor as a regulator for melanocytespecific transcription of the human tyrosinase gene. Mol. Cell RioJ. 14: 8058-8070. [Published erratum appears in 1995. Moi. Cell biol. 15:1833.1
778. Yen, A. and S. Varvayanis. 1995. The ratio of retinoblastoma (RB) to fos and RB to myc expression during the cell cycle. Proc. Soc. Exp. biol. MetJ. 210: 205-212.
779. Yieh, L., H. B. Sanchez, and T. F. Osborne. 1995. Domains of transcription factor Spl required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter. Proc. NatJ. Acad. Sci. U. S. A. 92: 6102-6106.
780. Yoon, S. O. and D. M. Chikaraishi. 1994. Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. J. RioJ. Chem. 269: 18453-18462.
781. Yoshida, S., A. Fujisawa Sehara, T. Taki, K. Aral, and Y. Nabeshima. 1996. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J. Cell biol. 132: 181-193.
782. 23 and c-myc genes in human prostatic LNCaP cells. Biochem, Biophys. Res. Commun. 208: 603-609.
783. Young, J., R. Buttenshaw, L. Butterworth, M. Ward, J. Searle, B. Leggett, and G. Chenevix Trench. 1994. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogens. 9: 1053-1056.
784. Yu, K., Q. Chen, H. Liu, Y. Zhan, and J. L. Stevens. 1994. Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells. J. CellPbysiol. 161: 303-311.
785. Zhang, H., N. Okamoto, and Y. Ikeda. 1995. Two c-myc genes from a tetraploid fish, the common carp (Cyprinus carpio). Gene 153: 231-236.
786. Zhang, R., F. W. Alt, L. Davidson, S. H. Orkin, and W. Swat. 1995. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374: 470-473.
787. Zhang, R., F. Y. Tsai, and S. H. Orkin. 1994. Hematopoietic development of vav-/- mouse embryonic stem cells. Pros. Natl. Acad. Sci. U. S. A. 91: 12755-12759.
788. Zhuang, Y., P. Cheng, and H. Weintraub. 1996. Blymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16: 2898-2905.
789. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79: 875-884.
790. Zijderveld, D. C., F. d'Adda di Fagagna, M. Giacca, H. T. Timmers, and P. C. van der Vliet. 1994. Stimulation of the adenovirus major late promoter in vitro by transcription factor USF is enhanced by the adenovirus DNA binding protein. J. Viral. 68: 8288-8295.
791. Zmuidzinas, A., K. D. Fischer, S. A. Lira, L. Forrester, S. Bryant, A. Bernstein, and M. Barbacid. 1995. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J. 14: 1-11.
792. Zornig, M., G. Busch, R. Beneke, E. Gulbins, F. Läng, A. Ma, S. Korsmeyer, and T. Moroy. 1995. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca fluxes. Qncogene. 11: 2165-2174.
793. Zornig, M., A. Grzeschiczek, M. B. Kowalski, K. U. Hartmann, and T. Moroy. 1995. Loss of as/Apo-1 receptor accelerates lymphomagenesis in Efj, L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogem. 10: 2397-2401. tructure/function relationships of HLH proteins
794. Hakoshima, T., Y. Teranishi, T. Ohira, K. Suzuki, M. Shimizu, M. Shirakawa, Y. Kyogoku, N. Ogawa, and Y. Oshima. 1993. Crystallographic characterization of a PHO4-DNA complex. J. Mol. biol. 229: 566-569.
795. Horimoto, K., H. Yamamoto, K. Yanagi, . Ohshima, and J. Otsuka. 1994. A simple procedure for assigning a sequence motif with an obscure pattern: application to the basic/helix-loop-helix motif. Protein. Eng. 7: 1433-1440.
796. Hua, X., J. Sakai, Y. K. Ho, J. L. Goldstein, and M. S. Brown. 1995. Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J. biol. Chem. 270: 29422-29427.
797. Johnson, N. P., J. Lindstrom, W. A. Baase, and P. H. von Hippel. 1994. Double-stranded DNA templates can induce a-helical conformation in peptides containing lysine and alanine: functional implications for leucine zipper and helix-loop-helix transcription factors. Proc. Natl. Acad. Sci. U. S. A. 91: 4840-4844.
798. Lavigne, P., L. H. Kondejewski, M. E. J. Houston, F. D. Sonnichsen, B. Lix, B. D. Skyes, R. S. Hodges, and C. M. Kay. 1995. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization. J. Mol. biol. 254: 505-520.
799. Muhle Goll, C., T. Gibson, P. Schuck, D. Schubert, D. Nalis, M. Nilges, and A. Pastore. 1994. The dimerization stability of the HLH-LZ transcription protein family is modulated by the leucine zippers: a CD and NMR study of TFEB and c-Myc. Biochemistry 33: 11296-11306.
800. Takemoto, C. and D. E. Fisher. 1995. Structural onstraints for DNA recognition by Myc and other bHLH-ZIP proteins: design of oncoprotein analogues. GeneExpr. 4: 311-317.
801. Wolberger, C. 1994. b/HLH without the zip. Nat. Struct. biol. 1: 413-416. equence-specific DNA binding by HLH proteins
802. Bacsi, S. G., S. Reisz Porszasz, and O. Hankinson. 995. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric
803. Barbarie, S., K. D. Fascher, and W. Horz. 1992. ctivation of the weakly regulated PHO8 promoter in S. cerevisiae-.àirommn transition and binding sites for the positive regulatory protein PHO4. Nucleic Acids Res. 20: 1031-1038. [Published erratum appears in 1992. Nucleic Acids Res. 20:1450.]
804. Bishop, P., C. Jones, I. Ghosh, and J. Chmielewski. 995. Synthesis of the basic-helix-loop-helix region of the immunoglobulin enhancer binding protein E47 and evaluation of its structural and DNA binding properties. Int. J. Pept. Protein. Res. 46: 149-154.
805. Briggs, M. R., C. Yokoyama, X. Wang, M. S. Brown, and J. L. Goldstein. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. biol. Chem. 268: 14490-14496.
806. Buckle, R. S. and M. Mechali. 1995. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autos uppression occurs via an indirect mechanism. Qncogem, 10: 1249-1255.
807. Czernik, P. J., C. A. Peterson, and B. K. Hurlburt. 1996. Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro. J. Biol. Chem. 271: 9141-9149.
808. 1. Dong, L., Q. Ma, and J. P. Whitlock. 1996. DNA binding by the hetcrodimeric Ah receptor. Relationship to dioxin-induced CYP1A1 transcription in vivo. J. biol. Chem. 271: 7942-'948.
809. Huang, J., T. K. Blackwell, L. Kedes, and . Weintraub. 1996. Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection. Mol. Cell. Biol. 16: 3893-3900.
810. Ireland, R. C., S. Y. Li, and J. J. Dougherty. 1995. The DNA binding of purified Ah receptor heterodimer is regulated by red ox conditions. Arch. Kiochem. Biophys. 319: 470-480.
811. Kim, J. B., G. D. Spotts, Y. D. Halvorsen, H. M. Shih, T. Ellenberger, H. C. Towle, and B. M. Spiegelman. 1995. Dual DNA binding specificity of ADD1/SREBP1 controlled by a sirgle amino acid in the basic helixloop-helix domain. Mol. Cell Biol. 15: 2582-2588.
812. Lecointe, N., O. Bernard, K. Naert, V. Joulin, . J. Larsen, P. H. Romeo, and D. Mathieu Mahul. 1994. GATA-and SPl-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene. 9: 2623-2632.
813. Lu, T. and M. Sawadogo. 1994. Role of the leucine zipper in the kinetics of DNA binding by transcription factor USF. J. Bio'. Chem. 269: 30694-30700.
814. McLane, K. E., 1). R. Burton, and P. Ghazal. 1995. Transplantation of a 17-amino acid -helical DNA-binding domain into an antibody molecule confers sequence-dependent DNA recognition. Proc. NatL Acad. Sci. U. S. A. 92: 5214-5218.
815. McLane, K. E. and J. P. J. Whitlock. 1994. DNA sequence requirements for Ah receptor/Arm recognition determined by in vitro transcription. Receptor. 4: 209-222.
816. Meierhan, D., C. el Ariss, M. Neuenschwander, M. Sieber, J. F. Stackhouse, and R. K. Allemann. 1995. DNA binding specificity of the basic-helix loop helix protein MASH-1, biochemistry 34: 11026-11036.
817. Mellor, J., J. Rathjen, W. Jiang, C. A. Barnes, and S. J. Dowell. 1991. DNA binding of CPF1 is required for optimal centromere function but not for maintaining methionine prototrophy in yeast. Nucleic Acids Res. 19: 2961-2969. [Published erratum appears in 1991. Nucleic Acids Res. 19:5112.]
818. Niedenthal, R. K., M. Sen Gupta, A. Wilmen, and J. H. Hegemann. 1993. Cpfl protein induced bending of yeast centromere DNA element I. Nucleic Acids Res. 21: 4726-4733.
819. Nielsen, A. L., N. Pallisgaard, F. S. Pedersen, and P. Jorgensen. 1994. Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J. Viral. 68: 5638-5647.
820. Okino, S. T. and J. P. J. Whitlock. 1995. Dioxin induces localized, graded changes in chromatin structure: implications for CyplAl gene transcription. Mol. Cell Rial. 15: 3714-3721.
821. Peyton, M., L. G. Moss, and M. J. Tsai. 1994. Two distinct class A helix-loop-helix transcription factors, E2A and BETA1, form separate DNA binding complexes on the insulin gene E box. J. biol. Cbem. 269: 25936-25941.
822. Sha, M., D. A. Ferre, S. K. Burley, and D. J. GOSS. 1995. Anti-cooperative biphasic equilibrium binding of transcription factor upstream stimulatory factor to its cognate DNA monitored by protein fluorescence changes. J. Bial. Cbem. 270: 19325-19329.
823. Swanson, H. I., W. K. Chan, and C. A. Bradfield. 995. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. biol. Chem. 270: 26292-26302.
824. Trepicchio, W. L. and T. G. Krontiris. 1993. 1GH minisatellite suppression of USF-binding-site- and E/jmediated transcriptional activation of the adenovirus major late promoter. Nucleic Acids Res. 21: 977-985.
825. Venter, U., J. Svaren, J. Schmilz, A. Schmid, and W. Horz. 1994. A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J. 13: 4848-4855.
826. Wechsler, D. S., O. Papoulas, C. V. Dang, and . E. Kingston. 1994. Differential binding of c-Myc and Max to nucleosomal DNA. Mol. Cell biol. 14: 4097-4107.
827. Weintraub, H., T. Genetta, and T. Kadesch. 1994. Tissue-specific gene activation by MyoD:determination of specificity by cis-acting repression elements. Genes. Dev. 8: 2203-2211.
828. Wilmen, A., H. Pick, R. K. Niedenthal, M. Sen Gupta, and J. H. Hegemann. 1994. The yeast centromere CDEI/Cpfl complex: differences between in vitro binding and in vivo functio Nucleic Acids Res. 22: 2791-2800. Dimerization partners
829. Alexandrova, N., J. Niklinski, V. Bliskovsky, G. A. Otterson, M. Blake, F. J. Kaye, and M. Zajac Kaye. 1995. The N-terminal domain of c-Myc associates with a-tubulin and microtubules in vivo and in vitro. Mol. Cell Biol. 15: 5188-5195.
830. 2120a. Bao, J. and A. S. Zervos. 1996. Isolation and characterization Nmil, a novel partner of Myc proteins. Oncogens 12: 2171-2176.
831. Bissonnette, R. P., A. McGahon, A. Mahboubi, and D. R. Green. 1994. Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J. Exp. Med. 180: 2413-2418.
832. Bresnick, E. H. and G. Felsenfeld. 1994. The leucine zipper is necessary for stabilizing a dimer of the helix-loop-helix transcription factor USF but not for maintenance of an elongated conformation. J. biol. Chem. 269: 21110-21116.
833. Bunker, C. A. and R. E. Kingston. 1995. Identification of a cDNA for SSRP1, an HMG-box protein, by interaction with the c-Myc oncoprotein in a novel bacterial expression screen. Nucleic Acids Res. 23: 269-276.
834. Bustelo, X. R., K. L. Suen, W. M. Michael, G. Dreyfuss, and M. Barbacid. 1995. Association of the vav proto-oncogene product with poly(rC)-spedfic RNA-binding proteins. Mol. Cell Biol. 15: 1324-1332.
835. Castresana, J. and M. Saraste. 1995. Does Vav bind to F-actin through a CH domain? FEES Lett. 374:149-151.
836. Fields, S. and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340: 245-246.
837. Goldfarb, A. N. and K. Lewandowska. 1994. Nuclear redirection of a cytoplasmic helix-loop-helix protein via heterodimerization with a nuclear localizing partner. Exp. Cell Res. 214:481-485.
838. Goldfarb, A. N., K. Lewandowska, and M. Shoham. 1996. Determinants of helix-loop-helix dimerization affinity. Random mutational analysis of SCL/tal. J. Biol. Cbem. 271: 2683-2688.
839. Hemesath, T. J., E. Steingrimsson, G. McGill, M. J. Hansen, J. Vaught, C. A. Hodgkinson, H. Arnheiter, N. G. Copeland, N. A. Jenkins, and D. E. Fisher. 1994. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes. Dev, 8: 2770-2780.
840. Robert, O., B. Jallal, J. Schlessinger, and A. Ullrich. 1994. Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. J. Biol. Cher. 269: 20225-20228.
841. Hossain, A., H. Kikuchi, S. Ikawa, I. Sagami, and M. Watanabe. 1995. Identification of a 120-kDa protein associated with aromatic hydrocarbon receptor nuclear translocator. Kochern. Biophys. Res. Commun. 212: 144-150.
842. 2 domain of proto-Vav. J. biol. Chem. 269: 32579-32585.
843. Laue, T. M., M. A. Starovasnik, H. Weintraub, X. H. Sun, L. Snider, and R. E. Klevit. 1995. MyoD forms micelles which can dissociate to form heterodimers with E47: implications of micellization on function. Proc. Natl. Acad. Sci. U. S. A. 92: 11824-11828.
844. Lindebro, M. C., L. PoelHnger, and M. L. Whitelaw. 1995. Protein-protein interaction via PAS domains: role of the PAS domain in positive and negative regulation of the bHLH/PAS dioxin receptor-Arnt transcription factor complex. EMBO J. 14: 3528-3539.
845. Lu, T., M. Van Dyke, and M. Sawadogo. 1993. Protein-protein interaction studies using immobilized oligohistidine fusion proteins. Anal. Biochem. 213: 318-322.
846. Machide, M., H. Mano, and K. Todokoro. 1995. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogens. 11: 619-625.
847. Mak, K. L., L. C. Longcor, S. E. Johnson, C. Lemercier, R. Q. To, and S. F. Konieczny. 1996. Examination of mammalian basic helix-loop-helix transcription factors using a yeast one-hybrid system. DNA Cell Biol. 15: 1-8.
848. Mao, Z. and B. Nadal-Ginard. 1996. Functional and physical interactions between mammalian achaete-scute homolog l and myocyte enhancer factor 2A. J. Biol. Chem. 271: 14371-14375.
849. Marchetti, A., M. Abril Marti, B. Illi, G. Cesareni, and S. Nasi. 1995. Analysis of the Myc and Max interaction specificity with A repressor-HLH domain fusions. J. Mol. Biol. 248: 541-550.
850. McGuire, J., P. Coumailleau, M. L. Whitelaw, J. A. Gustafsson, and L. Poellinger. 1995. The basic helix-loop-helix/PAS factor Sim is associated with hsp90. Implications for regulation by interaction with partner factors. J. Biol. Chem. 270: 31353-31357.
851. Mühle Goll, C, M. Nilges, and A. Pastore. 1995. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers. Biochemistry 34: 13554-13564.
852. 2/SH3 containing proteins in activated lymphocytes. Oncogem. 9: 1917-1923.
853. Ramos Morales, F., F. Romero, F. Schweighoffer, G. Bismuth, J. Camonis, M. Tortolero, and S. Fischer. 1995. The proline-rich region of Vav binds to Grb2 and Grb3-3. Omogene. 11: 1665-1669.
854. Ribon, V., T. Leff, and A. R. Saltiel. 1994. c-Myc does not require max for transcriptional activity in PC-12 cells. Mol. Cell Neurosci. 5: 277-282.
855. Romero, F., C. Dargemont, F. Pozo, W. H. Reeves, J. Camonis, S. Gisselbrecht, and S. Fischer. 1996. p95vav associates with the nuclear protein Ku-70. Mol. Cell biol. 16:37-44.
856. Schreiber Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxil mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser SIN3. Cell. 80: 777-786
857. Shirakata, M. and B. M. Paterson. 1995. The E12 nhibitory domair prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors. tiMBO J. 14: 1766-1772.
858. 2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell Rial. 14: 2777-2785.
859. Valge Archer, V. E., H. Osada, A. J. Warren, A. Forster, J. Li, R. Baer, and T. H. Rabbitts. 1994. The L1M protein RBTN2 and the basic helix-loop-helix protein TALI are present in a complex in erythroid cells. P roc. NatJ. Acad. Sci. U. S. A. 91: 8617-8621.
860. Van Seuningen, I., J. Ostrowski, X. R. Bustelo, P. R. Sleath, and K. Bomsztyk. 1995. The K protein domain that recruits the interleukin 1-responsive K protein kinase lies adjacent to a cluster of c-Src and Vav SH3-binding sites. Implications that K protein acts as a docking platform. J. Rial. Chem. 270: 26976-26985.
861. Wadman, L, J. Li, R. O. Bash, A. Forster, H. Osada, T. H. Rabbitts, and R. Baer. 1994. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 13: 4831-4839.
862. Weng, W. K., L. Jarvis, and T. W. LeBien. 1994. Signaling through GDI 9 activates Vav/mitogenactivated protein kinase pathway and induces formation of a CD19/Vav/phosphati-dylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269: 32514-32521.
863. Wenzel, A., C. Cziepluch, J. Schurmann, and M. Schwab. 1994. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins. Prog. Clin. Biol. Res. 385: 59-66.
864. Whitelaw, M. L, J. McGuire, D. Picard, J. A. Gustafsson, and L. Poellinger. 1995. Heat shock protein hsp90 regulates dioxin receptor function in vivo. P roc. Nail. Acad. Sci. U.S. A. 92: 4437-4441.
865. Yamaguchi, Y. and M. T. Kuo. 1995. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Biochem. Pharmacol. 50: 1295-1302.
866. Yavuzer, U. and C. R. Coding. 1994. Melanocytespecific gene expression: role of repression and identification of a melanocyte-specific factor, MSF. Mol. Cell Biol. 14: 3494-3503.
867. Yavuzer, U., E. Keenan, P. Lowing, J. Vachtenheim, G. Currie, and C. R. Coding. 1995. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Qncofem. 10: 123-134.
868. Ye, Z. S. and D. Baltimore. 1994. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. P roc. NatJ. Acad. Sa. U. S. A. 91: 12629-12633.
869. Zervos, 1994. Mxil, a protein that specificall interacts with Max to bind Myc-Max recognition sites. Cell 79:389. ost-transcriptional regulation of the activity of HLH proteins 2160.
870. Alai, M., A. L. Mui, R. L. Cutler, X. R. Bustelo, M. Barbacid, and G. Krystal. 1992. Steel factor stimulates the tyrosine phosphorylation of the protooncogene product, p95vav, in human hemopoietic cells. }. Viol. Chem. 267: 18021-18025.
871. Bousset, K., M. H. Oelgeschlager, M. Henriksson, S. Schreck, H. Burkhardt, D. W. Litchfield, J. M. Luscher Firzlaff, and B. Luscher. 1994. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell Mol. biol. Res. 40: 501-511.
872. Cheng, J. T., M. H. Cobb, and R. Baer. 1993. Phosphorylation of the TALI oncoprotein by the extracellular-signal-regulated protein kinase HRK1. Mol. Cell Biol. 13: 801-808.
873. Chou, T. Y., C. V. Dang, and G. W. Hart. 1995. Glycosylation of the c-Myc transactivation domain. froc. NatJ. Acad. Sci. U. S. A. 92: 4417-4421.
874. Darby, C., R. L. Geahlen, and A. D. Schreiber. 1994. Stimulation of macrophage Fc7 RIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein. J. Immunol. 152: 5429-5437.
875. Evans, G. A., O. M. Howard, R. Erwin, and W. L. Farrar. 1993. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase Ick. Biocbetn. J. 294: 339-342.
876. Gouy, H., P. Debre, and G. Bismuth. 1995. The proto-oncogene Vav product is constitutively tyrosi nephosphorylated in normal human immature T cells. Ear. J. Immunol. 25: 3030-3034.
877. 2-terminal activation domain of c-Myc. FEBS Lett. 353: 281-285.
878. Hanazono, Y., K. Sasaki, H. Odai, T. Mimura, K. Mitani, Y. Yazaki, and H. Hirai. 1995. Tyrosine phosphorylation of the proto-oncogene product Vav and its association with the adapter Grb2/Ash in a human leukemia cell line UT-7. ]pn. J. Cancer Res. 86: 336-341.
879. Johnson, S. E., X. Wang, S. Hardy, E. J. Taparowsky, and S. F. Konieczny. 1996. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol. Cell. biol. 16: 1604-1613.
880. Mahon, M. J. and T. A. Gasiewicz. 1995. Ah receptor phosphorylation: localization of phosphorylation sites to the C-terminal half of the protein. Arch. Biocbem. Biophys. 318: 166-174.
881. Matsuguchi, T., R. C. Inhorn, N. Carlesso, G. Xu, B. Druker, and J. D. Griffin. 1995. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 14: 257-265.
882. Miura, O., Y. Miura, N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki. 1994. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Stood. 84:4135-4141.
883. Nagata, Y., W. Shoji, M. Obinata, and K. Todokoro. 1995. Phosphorylation of helix-loop-helix proteins ID1, ID2 and 1D3. Biocbem. Biophys. Res. Commun. 207: 916-926.
884. O'Neill, E. M., A. Kaffman, E. R. Jolly, and E. K. O'Shea. 1996. Regulation of PHO4 nuclear localization by the PHO80-PHO85 cyclin-CDK complex. Science 271: 209-212.
885. Platanias, L. C. and M. E. Sweet. 1994. Interferon a induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem. 269: 3143-3146.
886. Sasaki, K., H. Odai, Y. Hanazono, H. Ueno, S. Ogawa, W. Y. Langdon, T. Tanaka, K. Miyagawa, K. Mitani, Y. Yazaki et al. 1995. TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem. Biophys. Res. Commun. 216: 338-347.
887. Uddin, S., S. Katzav, M. F. White, and L. C. Platanias. 1995. Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin. J. biol. Chem. 270: 7712-7716.
888. Yuo, A., S. Kitagawa, S. Iki, M. Yagisawa, E. K. Inuo, T. Mimura, S. Minoda, Y. Hanazono, H. Hirai, A. Urabe et at. 1995. Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colonystimulating factor. Biocbem. Biophys. Res. Commun. 211: 677-685.
889. Zervos, A. S., L. Faccio, J. P. Gatto, J. M. Kyriakis, and R. Brent. 1995. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc. Natl. Acad. Sci. U. S. A. 92: 10531-10534.